MPD: Measures involving CC8

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Auwerx2:1	Auwerx2	None	(none)	Submitter provided ID submitter_ID 114529 categorical informational CD HFD	inbred w/CC8	9	both		N=4	2021

Auwerx2:3	Auwerx2	body weight	(none)	body weight at 8 wks of age [g] bw_8wks 114531 CD HFD	inbred w/CC8	9	both	8wks	N=4	2021

Auwerx2:5	Auwerx2	body weight	(none)	body weight at 9 wks of age [g] bw_9wks 114533 CD HFD	inbred w/CC8	9	both	9wks	N=4	2021

Auwerx2:7	Auwerx2	body weight	(none)	body weight at 10 wks of age [g] bw_10wks 114535 CD HFD	inbred w/CC8	9	both	10wks	N=4	2021

Auwerx2:9	Auwerx2	body weight	(none)	body weight at 11 wks of age [g] bw_11wks 114537 CD HFD	inbred w/CC8	9	both	11wks	N=4	2021

Auwerx2:11	Auwerx2	body weight	(none)	body weight at 12 wks of age [g] bw_12wks 114539 CD HFD	inbred w/CC8	9	both	12wks	N=4	2021

Auwerx2:13	Auwerx2	body weight	(none)	body weight at 13 wks of age [g] bw_13wks 114541 CD HFD	inbred w/CC8	9	both	13wks	N=4	2021

Auwerx2:15	Auwerx2	body weight	(none)	body weight at 14 wks of age [g] bw_14wks 114543 CD HFD	inbred w/CC8	9	both	14wks	N=4	2021

Auwerx2:17	Auwerx2	body weight	(none)	body weight at 15 wks of age [g] bw_15wks 114545 CD HFD	inbred w/CC8	9	both	15wks	N=4	2021

Auwerx2:19	Auwerx2	body weight	(none)	body weight at 16 wks of age [g] bw_16wks 114547 CD HFD	inbred w/CC8	9	both	16wks	N=4	2021

Auwerx2:21	Auwerx2	body weight	(none)	body weight at 17 wks of age [g] bw_17wks 114549 CD HFD	inbred w/CC8	9	both	17wks	N=4	2021

Auwerx2:23	Auwerx2	body weight	(none)	body weight at 18 wks of age [g] bw_18wks 114551 CD HFD	inbred w/CC8	9	both	18wks	N=4	2021

Auwerx2:25	Auwerx2	body weight	(none)	body weight at 19 wks of age [g] bw_19wks 114553 CD HFD	inbred w/CC8	9	both	19wks	N=4	2021

Auwerx2:27	Auwerx2	body weight	(none)	body weight at 20 wks of age [g] bw_20wks 114555 CD HFD	inbred w/CC8	9	both	20wks	N=4	2021

Auwerx2:29	Auwerx2	body weight	(none)	body weight at 21 wks of age [g] bw_21wks 114557 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:31	Auwerx2	body weight	(none)	body weight measured by EchoMRI [g] bw_14wks_MRI 114559 CD HFD	inbred w/CC8	9	both	14wks	N=4	2021

Auwerx2:33	Auwerx2	MRI	(none)	fat tissue mass [g] fat 114561 CD HFD	inbred w/CC8	9	both	14wks	N=4	2021

Auwerx2:35	Auwerx2	MRI	(none)	lean tissue mass [g] ltm 114563 CD HFD	inbred w/CC8	9	both	14wks	N=4	2021

Auwerx2:37	Auwerx2	MRI	(none)	percentage fat tissue mass [%] fat_pct 114565 CD HFD	inbred w/CC8	9	both	14wks	N=4	2021

Auwerx2:39	Auwerx2	MRI	(none)	percentage lean tissue mass [%] ltm_pct 114567 CD HFD	inbred w/CC8	9	both	14wks	N=4	2021

Auwerx2:41	Auwerx2	monitoring system	(none)	oxygen consumption, 24h test, day time average [mL/kg/min] vo2_day 114569 CD HFD	inbred w/CC8	9	both	14wks	N=4	2021

Auwerx2:43	Auwerx2	monitoring system	(none)	oxygen consumption, 24h test, night time average [mL/kg/min] vo2_night 114571 CD HFD	inbred w/CC8	9	both	14wks	N=4	2021

Auwerx2:45	Auwerx2	monitoring system	(none)	carbon dioxide production, 24h test, day time average [mL/kg/min] vco2_day 114573 CD HFD	inbred w/CC8	9	both	14wks	N=4	2021

Auwerx2:47	Auwerx2	monitoring system	(none)	carbon dioxide production, 24h test, night time average [mL/kg/min] vco2_night 114575 CD HFD	inbred w/CC8	9	both	14wks	N=4	2021

Auwerx2:49	Auwerx2	monitoring system	(none)	respiratory exchange rate (VCO2:VO2), 24h test, day time average [ratio] rer_day 114577 CD HFD	inbred w/CC8	9	both	14wks	N=4	2021

Auwerx2:51	Auwerx2	monitoring system	(none)	respiratory exchange rate (VCO2:VO2), 24h test, night time average [ratio] rer_night 114579 CD HFD	inbred w/CC8	9	both	14wks	N=4	2021

Auwerx2:53	Auwerx2	body weight	(none)	body weight loss following 16h fast, prior to oral glucose tolerance test (OGTT), 16 wks of age [g] bw_16wks_ogtt 114581 CD HFD	inbred w/CC8	9	both	16wks	N=4	2021

Auwerx2:55	Auwerx2	glucose tolerance	(none)	glucose baseline, glucose tolerance test (pregavage, overnight fast) [mg/dL] ogtt_gluc_t0 114583 CD HFD	inbred w/CC8	9	both	16wks	N=4	2021

Auwerx2:57	Auwerx2	glucose tolerance	(none)	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 15 min [mg/dL] ogtt_gluc_t15 114585 CD HFD	inbred w/CC8	8	both	16wks	N=4	2021

Auwerx2:59	Auwerx2	glucose tolerance	(none)	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 30 min [mg/dL] ogtt_gluc_t30 114587 CD HFD	inbred w/CC8	8	both	16wks	N=4	2021

Auwerx2:61	Auwerx2	glucose tolerance	(none)	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 45 min [mg/dL] ogtt_gluc_t45 114589 CD HFD	inbred w/CC8	8	both	16wks	N=4	2021

Auwerx2:63	Auwerx2	glucose tolerance	(none)	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 60 min [mg/dL] ogtt_gluc_t60 114591 CD HFD	inbred w/CC8	8	both	16wks	N=4	2021

Auwerx2:65	Auwerx2	glucose tolerance	(none)	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 90 min [mg/dL] ogtt_gluc_t90 114593 CD HFD	inbred w/CC8	8	both	16wks	N=4	2021

Auwerx2:67	Auwerx2	glucose tolerance	(none)	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 120 min [mg/dL] ogtt_gluc_t120 114595 CD HFD	inbred w/CC8	8	both	16wks	N=4	2021

Auwerx2:69	Auwerx2	glucose tolerance	(none)	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 150 min [mg/dL] ogtt_gluc_t150 114597 CD HFD	inbred w/CC8	8	both	16wks	N=4	2021

Auwerx2:71	Auwerx2	glucose tolerance	(none)	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 180 min [mg/dL] ogtt_gluc_t180 114599 CD HFD	inbred w/CC8	8	both	16wks	N=4	2021

Auwerx2:73	Auwerx2	hormone quantification	(none)	insulin baseline, glucose tolerance test (pregavage, overnight fast) [µg/L] ogtt_ins_t0 114601 CD HFD	inbred w/CC8	9	both	16wks	N=4	2021

Auwerx2:75	Auwerx2	hormone quantification	(none)	insulin, glucose tolerance test (20% glucose oral gavage, overnight fast), after 15 min [µg/L] ogtt_ins_t15 114603 CD HFD	inbred w/CC8	8	both	16wks	N=4	2021

Auwerx2:77	Auwerx2	hormone quantification	(none)	insulin, glucose tolerance test (20% glucose oral gavage, overnight fast), after 30 min [µg/L] ogtt_ins_t30 114605 CD HFD	inbred w/CC8	8	both	16wks	N=4	2021

Auwerx2:79	Auwerx2	body temperature	(none)	body temperature (rectal) in cold (4°C) room, 0h exposed to cold [°C] temp_t0 114607 CD HFD	inbred w/CC8	9	both	18wks	N=4	2021

Auwerx2:81	Auwerx2	body temperature	(none)	body temperature (rectal) in cold (4°C) room, 1h exposed to cold [°C] temp_t1 114609 CD HFD	inbred w/CC8	9	both	18wks	N=4	2021

Auwerx2:83	Auwerx2	body temperature	(none)	body temperature (rectal) in cold (4°C) room, 2h exposed to cold [°C] temp_t2 114611 CD HFD	inbred w/CC8	9	both	18wks	N=4	2021

Auwerx2:85	Auwerx2	body temperature	(none)	body temperature (rectal) in cold (4°C) room, 3h exposed to cold [°C] temp_t3 114613 CD HFD	inbred w/CC8	9	both	18wks	N=4	2021

Auwerx2:87	Auwerx2	body temperature	(none)	body temperature (rectal) in cold (4°C) room, 4h exposed to cold [°C] temp_t4 114615 CD HFD	inbred w/CC8	9	both	18wks	N=4	2021

Auwerx2:89	Auwerx2	body temperature	(none)	body temperature (rectal) in cold (4°C) room, 5h exposed to cold [°C] temp_t5 114617 CD HFD	inbred w/CC8	9	both	18wks	N=4	2021

Auwerx2:91	Auwerx2	body temperature	(none)	body temperature (rectal) in cold (4°C) room, 6h exposed to cold [°C] temp_t6 114619 CD HFD	inbred w/CC8	9	both	18wks	N=4	2021

Auwerx2:93	Auwerx2	body weight	(none)	body weight, prior to basal activity test, at 19 wks of age [g] bw_19wks_basal 114621 CD HFD	inbred w/CC8	9	both	19wks	N=4	2021

Auwerx2:95	Auwerx2	monitoring system	(none)	horizontal activity (beam breaks) during day, basal activity test, for 48h [n/h] horiz_act_day 114623 CD HFD	inbred w/CC8	9	both	19wks	N=4	2021

Auwerx2:97	Auwerx2	monitoring system	(none)	vertical activity (beam breaks) during day, basal activity test, for 48h [n/h] vert_act_day 114625 CD HFD	inbred w/CC8	9	both	19wks	N=4	2021

Auwerx2:99	Auwerx2	monitoring system	(none)	horizontal activity (beam breaks) at night, basal activity test, for 48h [n/h] horiz_act_night 114627 CD HFD	inbred w/CC8	9	both	19wks	N=4	2021

Auwerx2:101	Auwerx2	monitoring system	(none)	vertical activity (beam breaks) at night, basal activity test, for 48h [n/h] vert_act_night 114629 CD HFD	inbred w/CC8	9	both	19wks	N=4	2021

Auwerx2:103	Auwerx2	intake monitoring	(none)	daily food intake, basal activity test, averaged over 2 days [g] food_intake 114631 CD HFD	inbred w/CC8	9	both	14wks	N=4	2021

Auwerx2:105	Auwerx2	monitoring system	(none)	basal oxygen consumption, prior to treadmill test [mL/kg/min] vo2_basal 114633 CD HFD	inbred w/CC8	9	both	19wks	N=4	2021

Auwerx2:107	Auwerx2	monitoring system	(none)	basal carbon dioxide production, prior to treadmill test [mL/kg/min] vco2_basal 114635 CD HFD	inbred w/CC8	9	both	19wks	N=4	2021

Auwerx2:109	Auwerx2	monitoring system	(none)	basal respiratory exchange ratio (RER), prior to treadmill test (VCO2:VO2), 15 min time period, last 2 min analyzed [ratio] rer_basal 114637 CD HFD	inbred w/CC8	9	both	19wks	N=4	2021

Auwerx2:111	Auwerx2	body weight	(none)	body weight, treadmill test [g] bw_treadmill 114639 CD HFD	inbred w/CC8	9	both	19wks	N=4	2021

Auwerx2:113	Auwerx2	monitoring system	(none)	maximum oxygen consumption, treadmill test [ratio] vo2_max_treadmill 114641 CD HFD	inbred w/CC8	9	both	19wks	N=4	2021

Auwerx2:115	Auwerx2	monitoring system	(none)	maximum carbon dioxide production, treadmill test [mL/kg/min] vco2_max_treadmill 114643 CD HFD	inbred w/CC8	9	both	19wks	N=4	2021

Auwerx2:117	Auwerx2	monitoring system	(none)	maximum respiratory exchange ratio (RER), treadmill test (VCO2:VO2) [ratio] rer_max_treadmill 114645 CD HFD	inbred w/CC8	9	both	19wks	N=4	2021

Auwerx2:119	Auwerx2	treadmill endurance test	(none)	distance traveled, treadmill test [m] dist_treadmill 114647 CD HFD	inbred w/CC8	9	both	19wks	N=4	2021

Auwerx2:121	Auwerx2	body weight	(none)	body weight at sacrifice [g] bw_21wks_sac 114649 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:123	Auwerx2	organ weights	(none)	cecum weight [g] cecum_wt 114651 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:125	Auwerx2	organ weights	(none)	gastrocnemius muscle weight [g] gastroc_wt 114653 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:127	Auwerx2	organ weights	(none)	heart weight [g] heart_wt 114655 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:129	Auwerx2	organ weights	(none)	heart atria weight [g] heart_atria_wt 114657 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:131	Auwerx2	organ weights	(none)	kidney weight (both) [g] kidney_wt 114659 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:133	Auwerx2	organ weights	(none)	liver weight [g] liver_wt 114661 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:135	Auwerx2	organ weights	(none)	spleen weight [g] spleen_wt 114663 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:137	Auwerx2	organ weights	(none)	gonadal fat pad weight [g] eWAT 114665 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:139	Auwerx2	organ weights	(none)	subcutaneous adipose tissue weight [g] subcut_adip_wt 114667 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:141	Auwerx2	organ dimensions	(none)	intestine length [cm] intestine_length 114669 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:143	Auwerx2	metabolic panel	(none)	plasma alanine transaminase amount (ALAT) [U/L] ALAT 114671 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:145	Auwerx2	metabolic panel	(none)	plasma aspartate transaminase amount (ASAT) [U/L] ASAT 114673 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:147	Auwerx2	metabolic panel	(none)	plasma creatinine amount [µmol/L] creatinine 114675 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:149	Auwerx2	metabolic panel	(none)	plasma iron amount [mmol/L] iron 114677 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:151	Auwerx2	metabolic panel	(none)	plasma lactate dehydrogenase amount (LDH) [U/L] LDH 114679 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:153	Auwerx2	metabolic panel	(none)	plasma lactate amount [mmol/L] lactate 114681 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:155	Auwerx2	metabolic panel	(none)	plasma urea nitrogen amount [mmol/L] urea 114683 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:157	Auwerx2	lipid profile	(none)	plasma cholesterol amount [mmol/L] chol 114685 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:159	Auwerx2	lipid profile	(none)	plasma HDL amount [mmol/L] hdl 114687 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:161	Auwerx2	lipid profile	(none)	plasma LDL amount [mmol/L] ldl 114689 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:163	Auwerx2	lipid profile	(none)	plasma triglyceride amount [mmol/L] triglyc 114691 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:165	Auwerx2	lipid profile	(none)	plasma free fatty acids amount [mmol/L] fatty_acids 114693 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Benavides1:1	Benavides1	genotype assessment	(none)	Gpr84 allele deletion in exon 2 (0=yes, 1=no) [designation] Gpr84 48201	inbred w/CC8	58	both	6wks		2013

Bubier3:1	Bubier3	monitoring system	morphine	minimum respiratory depression (breath rate, percentage of baseline), post injection [%] min_depression 64901	inbred w/CC8	8	both	8-24wks	N=6	2019

Bubier3:2	Bubier3	monitoring system	morphine	time to recovery for mice that survived, post injection [h] recovery_time 64902	inbred w/CC8	8	both	8-24wks	N=3	2019

Bubier3:3	Bubier3	monitoring system	morphine	survival time for mice that did not survive, post injection [h] survival_time 64903	inbred w/CC8	8	both	8-24wks	N=4	2019

Bubier3:4	Bubier3	monitoring system	morphine	survival after 24h ( 0=dead, 1=alive), post injection [score] survival_24h 64904	inbred w/CC8	8	both	8-24wks	N=6	2019

CGDpheno1:1	CGDpheno1	complete blood count	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 31801	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:2	CGDpheno1	complete blood count	(none)	red blood cell count (RBC; per volume x 10⁶) [n/µL] RBC 31802	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:5	CGDpheno1	complete blood count	(none)	neutrophil differential (NEUT; percentage of total WBC) [%] pctNEUT 31805	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:6	CGDpheno1	complete blood count	(none)	lymphocyte differential (LYM; percentage of total WBC) [%] pctLYMP 31806	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:7	CGDpheno1	complete blood count	(none)	monocyte differential (MONO; percentage of total WBC) [%] pctMONO 31807	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:8	CGDpheno1	complete blood count	(none)	eosinophil differential (EOS; percentage of total WBC) [%] pctEOS 31808	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:20	CGDpheno1	complete blood count	(none)	platelet count (PLT; units per volume x 10³) [n/µL] PLT 31820	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:21	CGDpheno1	complete blood count	(none)	mean platelet volume (MPV) [fL] MPV 31821	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:25	CGDpheno1	complete blood count	(none)	hematocrit (HCT) [%] HCT 31825	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:26	CGDpheno1	complete blood count	(none)	measured hemoglobin (HGB) [g/dL] mHGB 31826	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:27	CGDpheno1	complete blood count	(none)	mean RBC corpuscular volume (MCV) [fL] MCV 31827	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:28	CGDpheno1	complete blood count	(none)	mean RBC corpuscular hemoglobin content (MCH) [pg] MCH 31828	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:29	CGDpheno1	complete blood count	(none)	mean RBC corpuscular hemoglobin concentration (MCHC) [g/dL] MCHC 31829	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:31	CGDpheno1	complete blood count	(none)	RBC corpuscular distribution width (RDW) [%] RDW 31831	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:32	CGDpheno1	complete blood count	(none)	hemoglobin concentration distribution width (HDW) [g/dL] HDW 31832	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:34	CGDpheno1	complete blood count	(none)	reticulocyte differential (Retic; percentage of total RBC) [%] pct_Retic 31834	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:41	CGDpheno1	lipid profile	(none)	total cholesterol (plasma CHOL) [mg/dL] CHOL 31841	inbred w/CC8	72	both	12wks	N=7	2009

CGDpheno1:42	CGDpheno1	lipid profile	(none)	HDL cholesterol (plasma HDL) [mg/dL] HDLD 31842	inbred w/CC8	72	both	12wks	N=7	2009

CGDpheno1:45	CGDpheno1	lipid profile	(none)	triglycerides (plasma TG, 4h fast) [mg/dL] TG 31845	inbred w/CC8	72	both	12wks	N=7	2009

CGDpheno1:48	CGDpheno1	lipid profile	(none)	non-esterified free fatty acids (plasma NEFA, FFA) [mEq/L] NEFA 31848	inbred w/CC8	72	both	12wks	N=7	2009

CGDpheno1:50	CGDpheno1	metabolic panel	(none)	glucose (plasma GLU, 4h fast) [mg/dL] GLU 31850	inbred w/CC8	72	both	12wks	N=7	2009

CGDpheno1:55	CGDpheno1	metabolic panel	(none)	sodium (plasma Na) [mmol/L] sodium 31855	inbred w/CC8	72	both	12wks	N=8	2009

CGDpheno1:56	CGDpheno1	metabolic panel	(none)	potassium (plasma K) [mmol/L] potassium 31856	inbred w/CC8	72	both	12wks	N=8	2009

CGDpheno1:57	CGDpheno1	metabolic panel	(none)	chloride (plasma Cl) [mmol/L] chloride 31857	inbred w/CC8	72	both	12wks	N=8	2009

CGDpheno1:60	CGDpheno1	metabolic panel	(none)	total bilirubin (plasma TBIL) [µmol/L] TBIL 31860	inbred w/CC8	72	both	12wks	N=7	2009

CGDpheno1:61	CGDpheno1	metabolic panel	(none)	dissolved-ionized carbon dioxide (CO₂) [mmol/L] carbon_dioxide 31861	inbred w/CC8	72	both	12wks	N=8	2009

CGDpheno1:62	CGDpheno1	metabolic panel	(none)	blood urea nitrogen (BUN) [mg/dL] BUN 31862	inbred w/CC8	72	both	12wks	N=7	2009

CGDpheno1:70	CGDpheno1	metabolic panel	(none)	thyroxine (plasma T4) [µg/dL] T4 31870	inbred w/CC8	72	both	12wks	N=7	2009

CGDpheno3:1	CGDpheno3	metabolic panel	(none)	glucose (plasma GLU, 4h fast) [mg/dL] GLU 43901	CC diallel w/par	62	both	8wks	N=5	2012

CGDpheno3:2	CGDpheno3	lipid profile	(none)	total cholesterol (plasma CHOL) [mg/dL] CHOL 43902	CC diallel w/par	62	both	8wks	N=5	2012

CGDpheno3:3	CGDpheno3	lipid profile	(none)	HDL cholesterol (plasma HDL) [mg/dL] HDL 43903	CC diallel w/par	62	both	8wks	N=5	2012

CGDpheno3:4	CGDpheno3	lipid profile	(none)	triglycerides (plasma TG, 4h fast) [mg/dL] TG 43904	CC diallel w/par	62	both	8wks	N=5	2012

CGDpheno3:5	CGDpheno3	complete blood count	(none)	red blood cell count (RBC; per volume x 10⁶) [n/µL] RBC 43905	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:6	CGDpheno3	complete blood count	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 43906	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:7	CGDpheno3	complete blood count	(none)	lymphocyte differential (LYM; percentage of total WBC) [%] pctLYMP 43907	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:8	CGDpheno3	complete blood count	(none)	neutrophil differential (NEUT; percentage of total WBC) [%] pctNEUT 43908	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:9	CGDpheno3	complete blood count	(none)	monocyte differential (MONO; percentage of total WBC) [%] pctMONO 43909	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:10	CGDpheno3	complete blood count	(none)	basophil differential (BASO; percentage of total WBC) [%] pctBASO 43910	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:11	CGDpheno3	complete blood count	(none)	eosinophil differential (EOS; percentage of total WBC) [%] pctEOS 43911	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:12	CGDpheno3	complete blood count	(none)	large unstained cells (LUC; percentage of total WBC) [%] pctLUC 43912	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:13	CGDpheno3	complete blood count	(none)	reticulocyte differential (Retic; percentage of total RBC) [%] pctRetic 43913	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:14	CGDpheno3	complete blood count	(none)	RBC corpuscular distribution width (RDW) [%] RDW 43914	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:15	CGDpheno3	complete blood count	(none)	mean RBC corpuscular volume (MCV) [fL] MCV 43915	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:16	CGDpheno3	complete blood count	(none)	mean RBC corpuscular hemoglobin conent (MCH) [pg] MCH 43916	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:17	CGDpheno3	complete blood count	(none)	mean RBC corpuscular hemoglobin concentration (MCHC) [g/dL] MCHC 43917	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:18	CGDpheno3	complete blood count	(none)	RBC corpuscular hemoglobin concentration mean (CHCM) [g/dL] CHCM 43918	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:19	CGDpheno3	complete blood count	(none)	hemoglobin concentration distribution width (HDW) [g/dL] HDW 43919	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:20	CGDpheno3	complete blood count	(none)	measured hemoglobin (HGB) [g/dL] mHGB 43920	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:21	CGDpheno3	complete blood count	(none)	calculated hemoglobin (HGB) [g/dL] cHGB 43921	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:22	CGDpheno3	complete blood count	(none)	hematocrit (HCT) [%] HCT 43922	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:23	CGDpheno3	complete blood count	(none)	platelet count (PLT; units per volume x 10³) [n/µL] PLT 43923	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:24	CGDpheno3	complete blood count	(none)	mean platelet volume (MPV) [fL] MPV 43924	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:25	CGDpheno3	tail cuff	(none)	systolic blood pressure [mmHg] systolic_BP 43925	CC diallel w/par	24	both	10wks	N=4	2012

CGDpheno3:26	CGDpheno3	tail cuff	(none)	pulse rate [n/min] pulse 43926	CC diallel w/par	24	both	10wks	N=4	2012

CGDpheno3:27	CGDpheno3	ECG	(none)	heart rate [n/min] HR 43927	CC diallel w/par	42	both	12wks	N=5	2012

CGDpheno3:28	CGDpheno3	ECG	(none)	coefficient of variance, heart rate [%] CV 43928	CC diallel w/par	42	both	12wks	N=5	2012

CGDpheno3:29	CGDpheno3	ECG	(none)	R-wave amplitude [mV] R_amplitude 43929	CC diallel w/par	42	both	12wks	N=5	2012

CGDpheno3:30	CGDpheno3	ECG	(none)	R plus S-wave amplitude [mV] RS_amplitude 43930	CC diallel w/par	42	both	12wks	N=5	2012

CGDpheno3:31	CGDpheno3	ECG	(none)	interval between R-waves (RR) [ms] RR 43931	CC diallel w/par	42	both	12wks	N=5	2012

CGDpheno3:32	CGDpheno3	ECG	(none)	interval between peak of P-wave to Q-wave (PQ) [ms] PQ 43932	CC diallel w/par	42	both	12wks	N=5	2012

CGDpheno3:33	CGDpheno3	ECG	(none)	interval between peak of P-wave to R-wave (PR) [ms] PR 43933	CC diallel w/par	42	both	12wks	N=5	2012

CGDpheno3:34	CGDpheno3	ECG	(none)	interval between beginning and end of QRS complex [ms] QRS 43934	CC diallel w/par	42	both	12wks	N=5	2012

CGDpheno3:35	CGDpheno3	ECG	(none)	interval between peak of Q-wave to end of T-wave (QT) [ms] QT 43935	CC diallel w/par	42	both	12wks	N=5	2012

CGDpheno3:36	CGDpheno3	ECG	(none)	rate-corrected QT interval [ms] QTc 43936	CC diallel w/par	42	both	12wks	N=5	2012

CGDpheno3:37	CGDpheno3	ECG	(none)	difference between smallest and largest QT interval [ms] QT_dispersion 43937	CC diallel w/par	42	both	12wks	N=5	2012

CGDpheno3:38	CGDpheno3	ECG	(none)	difference between smallest and largest rate-corrected QT interval [ms] QTc_dispersion 43938	CC diallel w/par	42	both	12wks	N=5	2012

CGDpheno3:39	CGDpheno3	ECG	(none)	interval between S-wave and end of T-wave (ST) [ms] ST 43939	CC diallel w/par	42	both	12wks	N=5	2012

CGDpheno3:40	CGDpheno3	DXA	(none)	whole body bone mineral density (BMD) [g/cm²] BMD 43940	CC diallel w/par	62	both	16wks	N=5	2012

CGDpheno3:41	CGDpheno3	DXA	(none)	whole body bone mineral content (BMC) [g] BMC 43941	CC diallel w/par	62	both	16wks	N=5	2012

CGDpheno3:42	CGDpheno3	DXA	(none)	whole body bone area, head excluded [cm²] bone_area 43942	CC diallel w/par	62	both	16wks	N=5	2012

CGDpheno3:43	CGDpheno3	DXA	(none)	total body area without head [cm²] total_area 43943	CC diallel w/par	62	both	16wks	N=5	2012

CGDpheno3:44	CGDpheno3	DXA	(none)	weight of lean tissue mass, head excluded [g] LTM 43944	CC diallel w/par	62	both	16wks	N=5	2012

CGDpheno3:45	CGDpheno3	DXA	(none)	percent fat, head excluded [%] pct_fat 43945	CC diallel w/par	62	both	16wks	N=5	2012

CGDpheno3:46	CGDpheno3	DXA	(none)	total tissue mass, head excluded [g] TTM 43946	CC diallel w/par	62	both	16wks	N=5	2012

CGDpheno3:47	CGDpheno3	body weight	(none)	body weight [g] bw 43947	CC diallel w/par	62	both	16wks	N=5	2012

Chesler2:1	Chesler2	metabolic panel	(none)	sodium (blood Na) [mmol/L] sodium 43401	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:2	Chesler2	metabolic panel	(none)	potassium (blood K) [mmol/L] potassium 43402	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:3	Chesler2	metabolic panel	(none)	chloride (blood Cl) [mmol/L] chloride 43403	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:4	Chesler2	metabolic panel	(none)	calcium (blood ionized Ca) [mmol/L] calcium 43404	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:5	Chesler2	metabolic panel	(none)	anion gap concentration (mEq/L) [mmol/L] anion_gap 43405	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:6	Chesler2	metabolic panel	(none)	carbon dioxide (blood CO₂) [mmol/L] carbon_dioxide 43406	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:7	Chesler2	metabolic panel	(none)	glucose (blood GLU, no fast) [mg/dL] GLU 43407	CC diallel w/par	47	both	7-15wks	N=2	2011

Chesler2:8	Chesler2	metabolic panel	(none)	glucose (blood GLU, 16h fast) [mg/dL] GLU_fast 43408	CC diallel w/par	47	both	7-15wks	N=3	2011

Chesler2:9	Chesler2	metabolic panel	(none)	blood urea nitrogen (BUN) [mg/dL] BUN 43409	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:10	Chesler2	metabolic panel	(none)	creatinine (blood) [mg/dL] creatinine 43410	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:11	Chesler2	complete blood count	(none)	white blood cell count (WBC; units per volume x 10³) [n/µL] WBC 43413	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:12	Chesler2	complete blood count	(none)	lymphocyte count (LYM; units per volume x 10³) [n/µL] LYM 43414	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:13	Chesler2	complete blood count	(none)	lymphocyte differential (LYM; percentage of viable WBC) [%] pct_LYM 43415	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:14	Chesler2	complete blood count	(none)	monocyte count (MONO; units per volume x 10³) [n/µL] MONO 43416	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:15	Chesler2	complete blood count	(none)	monocyte differential (MONO; percentage of viable WBC) [%] pct_MONO 43417	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:16	Chesler2	complete blood count	(none)	granulocyte count (GRA; units per volume x 10³) [n/µL] GRA 43418	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:17	Chesler2	complete blood count	(none)	granulocyte differential (GRA; percentage of total viable WBC) [%] pct_GRA 43419	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:18	Chesler2	complete blood count	(none)	eosinophil differential (EOS; percentage of viable WBC) [%] pct_EOS 43420	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:19	Chesler2	complete blood count	(none)	red blood cell count (RBC; units per volume x 10⁶) [n/µL] RBC 43421	CC diallel w/par	49	both	7-15wks	N=2	2011

Chesler2:20	Chesler2	complete blood count	(none)	mean RBC corpuscular volume (MCV) [fL] MCV 43422	CC diallel w/par	49	both	7-15wks	N=2	2011

Chesler2:21	Chesler2	complete blood count	(none)	RBC corpuscular distribution width (RDW) [%] RDW 43423	CC diallel w/par	49	both	7-15wks	N=2	2011

Chesler2:22	Chesler2	complete blood count	(none)	mean RBC corpuscular hemoglobin (MCH) [pg] MCH 43424	CC diallel w/par	49	both	7-15wks	N=2	2011

Chesler2:23	Chesler2	complete blood count	(none)	mean RBC corpuscular hemoglobin concentration (MCHC) [g/dL] MCHC 43425	CC diallel w/par	49	both	7-15wks	N=2	2011

Chesler2:24	Chesler2	complete blood count	(none)	hemoglobin (HGB) [g/dL] hemoglobin 43426	CC diallel w/par	49	both	7-15wks	N=2	2011

Chesler2:25	Chesler2	complete blood count	(none)	hematocrit (HCT) [%] hematocrit 43427	CC diallel w/par	49	both	7-15wks	N=2	2011

Chesler2:26	Chesler2	complete blood count	(none)	platelet count (PLT; units per volume x 10³) [n/µL] platelets 43428	CC diallel w/par	49	both	7-15wks	N=2	2011

Chesler2:27	Chesler2	complete blood count	(none)	mean platelet volume (MPV) [fL] MPV 43429	CC diallel w/par	49	both	7-15wks	N=2	2011

Chesler2:28	Chesler2	colony observation	(none)	number of mice born in first litter [n] litter_size 43441	CC diallel w/par	62	both	4wks	N=8	2011

Chesler2:29	Chesler2	colony observation	(none)	parental age at first litter [d] age_first_litter 43442	CC diallel w/par	62	both	4wks	N=8	2011

Chesler2:30	Chesler2	colony observation	(none)	time from mate to first litter [d] duration_to_litter 43443	CC diallel w/par	62	both	4wks	N=8	2011

Chesler2:31	Chesler2	open field test	(none)	distance traveled during first 3 min, 10 min test [cm] distance3_OFT 43451	CC diallel w/par	50	both	7-15wks	N=2	2011

Chesler2:32	Chesler2	open field test	(none)	distance traveled, 10 min test [cm] distance10_OFT 43452	CC diallel w/par	50	both	7-15wks	N=2	2011

Chesler2:33	Chesler2	open field test	(none)	number of transitions between center and periphery, 10 min test [n] transitions_OFT 43453	CC diallel w/par	50	both	7-15wks	N=2	2011

Chesler2:34	Chesler2	open field test	(none)	time spent in center during first minute, 10 min test [s] center1_OFT 43454	CC diallel w/par	50	both	7-15wks	N=2	2011

Chesler2:35	Chesler2	open field test	(none)	time spent in center, 10 min test [s] center10_OFT 43455	CC diallel w/par	50	both	7-15wks	N=2	2011

Chesler2:36	Chesler2	open field test	(none)	integrated distance from absolute center, 10 min test [cm] distance_center_OFT 43456	CC diallel w/par	50	both	7-15wks	N=2	2011

Chesler2:37	Chesler2	open field test	(none)	percentage of time in center, 10 min test [%] pct_center_OFT 43457	CC diallel w/par	50	both	7-15wks	N=2	2011

Chesler2:38	Chesler2	open field test	(none)	latency to reach periphery, 10 min test [s] latency_periphery_OFT 43458	CC diallel w/par	50	both	7-15wks	N=2	2011

Chesler2:39	Chesler2	open field test	(none)	time spent in periphery, 10 min test [s] duration_periphery_OFT 43459	CC diallel w/par	50	both	7-15wks	N=2	2011

Chesler2:40	Chesler2	open field test	(none)	time spent immobile during first minute, 10 min test [s] immobile_OFT 43460	CC diallel w/par	50	both	7-15wks	N=2	2011

Chesler2:41	Chesler2	open field test	(none)	number of fecal boli, 10 min test [n] fecal_boli_OFT 43461	CC diallel w/par	50	both	7-15wks	N=2	2011

Chesler2:42	Chesler2	open field test	(none)	number of urine puddles, 10 min test [n] urination_OFT 43462	CC diallel w/par	50	both	7-15wks	N=2	2011

Chesler2:43	Chesler2	light-dark box	(none)	time spent in light compartment, 10 min test [min] duration_light_LD 43463	CC diallel w/par	50	both	7-15wks	N=2	2011

Chesler2:44	Chesler2	light-dark box	(none)	distance traveled in light compartment, 10 min test [cm] distance_light_LD 43464	CC diallel w/par	50	both	7-15wks	N=2	2011

Chesler2:45	Chesler2	light-dark box	(none)	percentage of time in light compartment, 10 min test [%] pct_light_LD 43465	CC diallel w/par	50	both	7-15wks	N=2	2011

Chesler2:46	Chesler2	light-dark box	(none)	latency to enter dark compartment, 10 min test [s] latency_dark_LD 43466	CC diallel w/par	50	both	7-15wks	N=2	2011

Chesler2:47	Chesler2	light-dark box	(none)	number of transitions between light and dark compartments, 10 min test [n] transitions_LD 43467	CC diallel w/par	50	both	7-15wks	N=2	2011

Chesler2:48	Chesler2	light-dark box	(none)	number of fecal boli, 10 min test [n] fecal_boli_LD 43468	CC diallel w/par	50	both	7-15wks	N=2	2011

Chesler2:49	Chesler2	light-dark box	(none)	number of urine puddles, 10 min test [n] urination_LD 43469	CC diallel w/par	50	both	7-15wks	N=2	2011

Chesler2:50	Chesler2	behavior observation	(none)	response to capture [score] capture_score 43470	CC diallel w/par	62	both	7-15wks	N=8	2011

Chesler2:51	Chesler2	behavior observation	(none)	response to holding [score] hold_score 43471	CC diallel w/par	62	both	7-15wks	N=8	2011

Chesler2:52	Chesler2	behavior observation	(none)	capture and hold scores combined [score] wildness_score 43472	CC diallel w/par	62	both	7-15wks	N=8	2011

Chesler2:53	Chesler2	nociception assay	(none)	latency of nociceptive response to pressure on the tail, 60 s test [s] tail_clip 43473	CC diallel w/par	56	both	7-15wks	N=3	2011

Chesler2:54	Chesler2	nociception assay	(none)	latency of nociceptive response to hot plate (54°C), 30 s test [s] hot_plate 43474	CC diallel w/par	56	both	7-15wks	N=3	2011

Chesler2:55	Chesler2	monitoring system	(none)	percentage of time spent sleeping, baseline [%] pct_sleep_daily 43481	CC diallel w/par	57	both	7-15wks	N=3	2011

Chesler2:56	Chesler2	monitoring system	(none)	percentage of time spent sleeping during dark period, baseline [%] pct_sleep_dark 43482	CC diallel w/par	57	both	7-15wks	N=3	2011

Chesler2:57	Chesler2	monitoring system	(none)	percentage of time spent sleeping, following sleep deprivation [%] pct_daily_deprivation 43483	CC diallel w/par	57	both	7-15wks	N=2	2011

Chesler2:58	Chesler2	monitoring system	(none)	percentage of time spent sleeping during dark period, following sleep deprivation [%] pct_dark_deprivation 43484	CC diallel w/par	57	both	7-15wks	N=2	2011

Chesler2:59	Chesler2	monitoring system	(none)	peak activity time from dark onset, following sleep deprivation [h] act_dark_deprivation 43485	CC diallel w/par	57	both	7-15wks	N=2	2011

Chesler2:60	Chesler2	body size and weight	(none)	body weight [g] body_weight 43486	CC diallel w/par	56	both	7-15wks	N=3	2011

Chesler2:61	Chesler2	body size and weight	(none)	tail length [cm] tail_length 43488	CC diallel w/par	47	both	7-15wks	N=3	2011

Chesler2:62	Chesler2	fat pad weights	(none)	gonadal fat pad weight [g] gonad_fat_wt 43489	CC diallel w/par	46	both	7-15wks	N=3	2011

Chesler2:63	Chesler2	organ weights	(none)	heart weight [g] heart_wt 43492	CC diallel w/par	46	both	7-15wks	N=3	2011

Chesler2:64	Chesler2	organ weights	(none)	kidney (left) weight [g] kidneyL_wt 43496	CC diallel w/par	46	both	7-15wks	N=3	2011

Chesler3:1	Chesler3	metabolic panel	(none)	sodium (blood Na) [mmol/L] sodium 43501	CC pre w/par	190	both	7-15wks	N=1	2011

Chesler3:2	Chesler3	metabolic panel	(none)	potassium (blood K) [mmol/L] potassium 43502	CC pre w/par	190	both	7-15wks	N=1	2011

Chesler3:3	Chesler3	metabolic panel	(none)	chloride (blood Cl) [mmol/L] chloride 43503	CC pre w/par	190	both	7-15wks	N=1	2011

Chesler3:4	Chesler3	metabolic panel	(none)	calcium (blood ionized Ca) [mmol/L] calcium 43504	CC pre w/par	190	both	7-15wks	N=1	2011

Chesler3:5	Chesler3	metabolic panel	(none)	anion gap concentration (mEq/L) [mmol/L] anion_gap 43505	CC pre w/par	187	both	7-15wks	N=1	2011

Chesler3:6	Chesler3	metabolic panel	(none)	carbon dioxide (blood CO₂) [mmol/L] carbon_dioxide 43506	CC pre w/par	189	both	7-15wks	N=1	2011

Chesler3:7	Chesler3	metabolic panel	(none)	glucose (blood GLU, no fast) [mg/dL] GLU 43507	CC pre w/par	190	both	7-15wks	N=1	2011

Chesler3:8	Chesler3	metabolic panel	(none)	glucose (blood GLU, 16h fast) [mg/dL] GLU_fast 43508	CC pre w/par	275	both	7-15wks	N=2	2011

Chesler3:9	Chesler3	metabolic panel	(none)	blood urea nitrogen (BUN) [mg/dL] BUN 43509	CC pre w/par	190	both	7-15wks	N=1	2011

Chesler3:10	Chesler3	metabolic panel	(none)	creatinine (blood) [mg/dL] creatinine 43510	CC pre w/par	189	both	7-15wks	N=1	2011

Chesler3:13	Chesler3	complete blood count	(none)	white blood cell count (WBC; units per volume x 10³) [n/µL] WBC 43513	CC pre w/par	199	both	7-15wks	N=1	2011

Chesler3:14	Chesler3	complete blood count	(none)	lymphocyte count (LYM; units per volume x 10³) [n/µL] LYM 43514	CC pre w/par	198	both	7-15wks	N=1	2011

Chesler3:15	Chesler3	complete blood count	(none)	lymphocyte differential (LYM; percentage of viable WBC) [%] pct_LYM 43515	CC pre w/par	198	both	7-15wks	N=1	2011

Chesler3:16	Chesler3	complete blood count	(none)	monocyte count (MONO; units per volume x 10³) [n/µL] MONO 43516	CC pre w/par	198	both	7-15wks	N=1	2011

Chesler3:17	Chesler3	complete blood count	(none)	monocyte differential (MONO; percentage of viable WBC) [%] pct_MONO 43517	CC pre w/par	198	both	7-15wks	N=1	2011

Chesler3:18	Chesler3	complete blood count	(none)	granulocyte count (GRA; units per volume x 10³) [n/µL] GRA 43518	CC pre w/par	198	both	7-15wks	N=1	2011

Chesler3:19	Chesler3	complete blood count	(none)	granulocyte differential (GRA; percentage of total viable WBC) [%] pct_GRA 43519	CC pre w/par	198	both	7-15wks	N=1	2011

Chesler3:20	Chesler3	complete blood count	(none)	eosinophil differential (EOS; percentage of viable WBC) [%] pct_EOS 43520	CC pre w/par	198	both	7-15wks	N=1	2011

Chesler3:21	Chesler3	complete blood count	(none)	red blood cell count (RBC; units per volume x 10⁶) [n/µL] RBC 43521	CC pre w/par	200	both	7-15wks	N=1	2011

Chesler3:22	Chesler3	complete blood count	(none)	mean RBC corpuscular volume (MCV) [fL] MCV 43522	CC pre w/par	200	both	7-15wks	N=1	2011

Chesler3:23	Chesler3	complete blood count	(none)	RBC corpuscular distribution width (RDW) [%] RDW 43523	CC pre w/par	200	both	7-15wks	N=1	2011

Chesler3:24	Chesler3	complete blood count	(none)	mean RBC corpuscular hemoglobin (MCH) [pg] MCH 43524	CC pre w/par	200	both	7-15wks	N=1	2011

Chesler3:25	Chesler3	complete blood count	(none)	mean RBC corpuscular hemoglobin concentration (MCHC) [g/dL] MCHC 43525	CC pre w/par	200	both	7-15wks	N=1	2011

Auwerx2

None

(none)

Submitter provided ID submitter_ID 114529 categorical informational CD HFD

inbred w/CC8

9

both

N=4

2021

Auwerx2

body weight

(none)

body weight at 8 wks of age [g] bw_8wks 114531 CD HFD

inbred w/CC8

9

both

8wks

N=4

2021

Auwerx2

body weight

(none)

body weight at 9 wks of age [g] bw_9wks 114533 CD HFD

inbred w/CC8

9

both

9wks

N=4

2021

Auwerx2

body weight

(none)

body weight at 10 wks of age [g] bw_10wks 114535 CD HFD

inbred w/CC8

9

both

10wks

N=4

2021

Auwerx2

body weight

(none)

body weight at 11 wks of age [g] bw_11wks 114537 CD HFD

inbred w/CC8

9

both

11wks

N=4

2021

Auwerx2

body weight

(none)

body weight at 12 wks of age [g] bw_12wks 114539 CD HFD

inbred w/CC8

9

both

12wks

N=4

2021

Auwerx2

body weight

(none)

body weight at 13 wks of age [g] bw_13wks 114541 CD HFD

inbred w/CC8

9

both

13wks

N=4

2021

Auwerx2

body weight

(none)

body weight at 14 wks of age [g] bw_14wks 114543 CD HFD

inbred w/CC8

9

both

14wks

N=4

2021

Auwerx2

body weight

(none)

body weight at 15 wks of age [g] bw_15wks 114545 CD HFD

inbred w/CC8

9

both

15wks

N=4

2021

Auwerx2

body weight

(none)

body weight at 16 wks of age [g] bw_16wks 114547 CD HFD

inbred w/CC8

9

both

16wks

N=4

2021

Auwerx2

body weight

(none)

body weight at 17 wks of age [g] bw_17wks 114549 CD HFD

inbred w/CC8

9

both

17wks

N=4

2021

Auwerx2

body weight

(none)

body weight at 18 wks of age [g] bw_18wks 114551 CD HFD

inbred w/CC8

9

both

18wks

N=4

2021

Auwerx2

body weight

(none)

body weight at 19 wks of age [g] bw_19wks 114553 CD HFD

inbred w/CC8

9

both

19wks

N=4

2021

Auwerx2

body weight

(none)

body weight at 20 wks of age [g] bw_20wks 114555 CD HFD

inbred w/CC8

9

both

20wks

N=4

2021

Auwerx2

body weight

(none)

body weight at 21 wks of age [g] bw_21wks 114557 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Auwerx2

body weight

(none)

body weight measured by EchoMRI [g] bw_14wks_MRI 114559 CD HFD

inbred w/CC8

9

both

14wks

N=4

2021

Auwerx2

MRI

(none)

fat tissue mass [g] fat 114561 CD HFD

inbred w/CC8

9

both

14wks

N=4

2021

Auwerx2

MRI

(none)

lean tissue mass [g] ltm 114563 CD HFD

inbred w/CC8

9

both

14wks

N=4

2021

Auwerx2

MRI

(none)

percentage fat tissue mass [%] fat_pct 114565 CD HFD

inbred w/CC8

9

both

14wks

N=4

2021

Auwerx2

MRI

(none)

percentage lean tissue mass [%] ltm_pct 114567 CD HFD

inbred w/CC8

9

both

14wks

N=4

2021

Auwerx2

monitoring system

(none)

oxygen consumption, 24h test, day time average [mL/kg/min] vo2_day 114569 CD HFD

inbred w/CC8

9

both

14wks

N=4

2021

Auwerx2

monitoring system

(none)

oxygen consumption, 24h test, night time average [mL/kg/min] vo2_night 114571 CD HFD

inbred w/CC8

9

both

14wks

N=4

2021

Auwerx2

monitoring system

(none)

carbon dioxide production, 24h test, day time average [mL/kg/min] vco2_day 114573 CD HFD

inbred w/CC8

9

both

14wks

N=4

2021

Auwerx2

monitoring system

(none)

carbon dioxide production, 24h test, night time average [mL/kg/min] vco2_night 114575 CD HFD

inbred w/CC8

9

both

14wks

N=4

2021

Auwerx2

monitoring system

(none)

respiratory exchange rate (VCO2:VO2), 24h test, day time average [ratio] rer_day 114577 CD HFD

inbred w/CC8

9

both

14wks

N=4

2021

Auwerx2

monitoring system

(none)

respiratory exchange rate (VCO2:VO2), 24h test, night time average [ratio] rer_night 114579 CD HFD

inbred w/CC8

9

both

14wks

N=4

2021

Auwerx2

body weight

(none)

body weight loss following 16h fast, prior to oral glucose tolerance test (OGTT), 16 wks of age [g] bw_16wks_ogtt 114581 CD HFD

inbred w/CC8

9

both

16wks

N=4

2021

Auwerx2

glucose tolerance

(none)

glucose baseline, glucose tolerance test (pregavage, overnight fast) [mg/dL] ogtt_gluc_t0 114583 CD HFD

inbred w/CC8

9

both

16wks

N=4

2021

Auwerx2

glucose tolerance

(none)

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 15 min [mg/dL] ogtt_gluc_t15 114585 CD HFD

inbred w/CC8

8

both

16wks

N=4

2021

Auwerx2

glucose tolerance

(none)

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 30 min [mg/dL] ogtt_gluc_t30 114587 CD HFD

inbred w/CC8

8

both

16wks

N=4

2021

Auwerx2

glucose tolerance

(none)

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 45 min [mg/dL] ogtt_gluc_t45 114589 CD HFD

inbred w/CC8

8

both

16wks

N=4

2021

Auwerx2

glucose tolerance

(none)

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 60 min [mg/dL] ogtt_gluc_t60 114591 CD HFD

inbred w/CC8

8

both

16wks

N=4

2021

Auwerx2

glucose tolerance

(none)

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 90 min [mg/dL] ogtt_gluc_t90 114593 CD HFD

inbred w/CC8

8

both

16wks

N=4

2021

Auwerx2

glucose tolerance

(none)

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 120 min [mg/dL] ogtt_gluc_t120 114595 CD HFD

inbred w/CC8

8

both

16wks

N=4

2021

Auwerx2

glucose tolerance

(none)

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 150 min [mg/dL] ogtt_gluc_t150 114597 CD HFD

inbred w/CC8

8

both

16wks

N=4

2021

Auwerx2

glucose tolerance

(none)

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 180 min [mg/dL] ogtt_gluc_t180 114599 CD HFD

inbred w/CC8

8

both

16wks

N=4

2021

Auwerx2

hormone quantification

(none)

insulin baseline, glucose tolerance test (pregavage, overnight fast) [µg/L] ogtt_ins_t0 114601 CD HFD

inbred w/CC8

9

both

16wks

N=4

2021

Auwerx2

hormone quantification

(none)

insulin, glucose tolerance test (20% glucose oral gavage, overnight fast), after 15 min [µg/L] ogtt_ins_t15 114603 CD HFD

inbred w/CC8

8

both

16wks

N=4

2021

Auwerx2

hormone quantification

(none)

insulin, glucose tolerance test (20% glucose oral gavage, overnight fast), after 30 min [µg/L] ogtt_ins_t30 114605 CD HFD

inbred w/CC8

8

both

16wks

N=4

2021

Auwerx2

body temperature

(none)

body temperature (rectal) in cold (4°C) room, 0h exposed to cold [°C] temp_t0 114607 CD HFD

inbred w/CC8

9

both

18wks

N=4

2021

Auwerx2

body temperature

(none)

body temperature (rectal) in cold (4°C) room, 1h exposed to cold [°C] temp_t1 114609 CD HFD

inbred w/CC8

9

both

18wks

N=4

2021

Auwerx2

body temperature

(none)

body temperature (rectal) in cold (4°C) room, 2h exposed to cold [°C] temp_t2 114611 CD HFD

inbred w/CC8

9

both

18wks

N=4

2021

Auwerx2

body temperature

(none)

body temperature (rectal) in cold (4°C) room, 3h exposed to cold [°C] temp_t3 114613 CD HFD

inbred w/CC8

9

both

18wks

N=4

2021

Auwerx2

body temperature

(none)

body temperature (rectal) in cold (4°C) room, 4h exposed to cold [°C] temp_t4 114615 CD HFD

inbred w/CC8

9

both

18wks

N=4

2021

Auwerx2

body temperature

(none)

body temperature (rectal) in cold (4°C) room, 5h exposed to cold [°C] temp_t5 114617 CD HFD

inbred w/CC8

9

both

18wks

N=4

2021

Auwerx2

body temperature

(none)

body temperature (rectal) in cold (4°C) room, 6h exposed to cold [°C] temp_t6 114619 CD HFD

inbred w/CC8

9

both

18wks

N=4

2021

Auwerx2

body weight

(none)

body weight, prior to basal activity test, at 19 wks of age [g] bw_19wks_basal 114621 CD HFD

inbred w/CC8

9

both

19wks

N=4

2021

Auwerx2

monitoring system

(none)

horizontal activity (beam breaks) during day, basal activity test, for 48h [n/h] horiz_act_day 114623 CD HFD

inbred w/CC8

9

both

19wks

N=4

2021

Auwerx2

monitoring system

(none)

vertical activity (beam breaks) during day, basal activity test, for 48h [n/h] vert_act_day 114625 CD HFD

inbred w/CC8

9

both

19wks

N=4

2021

Auwerx2

monitoring system

(none)

horizontal activity (beam breaks) at night, basal activity test, for 48h [n/h] horiz_act_night 114627 CD HFD

inbred w/CC8

9

both

19wks

N=4

2021

Auwerx2

monitoring system

(none)

vertical activity (beam breaks) at night, basal activity test, for 48h [n/h] vert_act_night 114629 CD HFD

inbred w/CC8

9

both

19wks

N=4

2021

Auwerx2

intake monitoring

(none)

daily food intake, basal activity test, averaged over 2 days [g] food_intake 114631 CD HFD

inbred w/CC8

9

both

14wks

N=4

2021

Auwerx2

monitoring system

(none)

basal oxygen consumption, prior to treadmill test [mL/kg/min] vo2_basal 114633 CD HFD

inbred w/CC8

9

both

19wks

N=4

2021

Auwerx2

monitoring system

(none)

basal carbon dioxide production, prior to treadmill test [mL/kg/min] vco2_basal 114635 CD HFD

inbred w/CC8

9

both

19wks

N=4

2021

Auwerx2

monitoring system

(none)

basal respiratory exchange ratio (RER), prior to treadmill test (VCO2:VO2), 15 min time period, last 2 min analyzed [ratio] rer_basal 114637 CD HFD

inbred w/CC8

9

both

19wks

N=4

2021

Auwerx2

body weight

(none)

body weight, treadmill test [g] bw_treadmill 114639 CD HFD

inbred w/CC8

9

both

19wks

N=4

2021

Auwerx2

monitoring system

(none)

maximum oxygen consumption, treadmill test [ratio] vo2_max_treadmill 114641 CD HFD

inbred w/CC8

9

both

19wks

N=4

2021

Auwerx2

monitoring system

(none)

maximum carbon dioxide production, treadmill test [mL/kg/min] vco2_max_treadmill 114643 CD HFD

inbred w/CC8

9

both

19wks

N=4

2021

Auwerx2

monitoring system

(none)

maximum respiratory exchange ratio (RER), treadmill test (VCO2:VO2) [ratio] rer_max_treadmill 114645 CD HFD

inbred w/CC8

9

both

19wks

N=4

2021

Auwerx2

treadmill endurance test

(none)

distance traveled, treadmill test [m] dist_treadmill 114647 CD HFD

inbred w/CC8

9

both

19wks

N=4

2021

Auwerx2

body weight

(none)

body weight at sacrifice [g] bw_21wks_sac 114649 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Auwerx2

organ weights

(none)

cecum weight [g] cecum_wt 114651 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Auwerx2

organ weights

(none)

gastrocnemius muscle weight [g] gastroc_wt 114653 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Auwerx2

organ weights

(none)

heart weight [g] heart_wt 114655 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Auwerx2

organ weights

(none)

heart atria weight [g] heart_atria_wt 114657 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Auwerx2

organ weights

(none)

kidney weight (both) [g] kidney_wt 114659 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Auwerx2

organ weights

(none)

liver weight [g] liver_wt 114661 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Auwerx2

organ weights

(none)

spleen weight [g] spleen_wt 114663 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Auwerx2

organ weights

(none)

gonadal fat pad weight [g] eWAT 114665 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Auwerx2

organ weights

(none)

subcutaneous adipose tissue weight [g] subcut_adip_wt 114667 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Auwerx2

organ dimensions

(none)

intestine length [cm] intestine_length 114669 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Auwerx2

metabolic panel

(none)

plasma alanine transaminase amount (ALAT) [U/L] ALAT 114671 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Auwerx2

metabolic panel

(none)

plasma aspartate transaminase amount (ASAT) [U/L] ASAT 114673 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Auwerx2

metabolic panel

(none)

plasma creatinine amount [µmol/L] creatinine 114675 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Auwerx2

metabolic panel

(none)

plasma iron amount [mmol/L] iron 114677 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Auwerx2

metabolic panel

(none)

plasma lactate dehydrogenase amount (LDH) [U/L] LDH 114679 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Auwerx2

metabolic panel

(none)

plasma lactate amount [mmol/L] lactate 114681 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Auwerx2

metabolic panel

(none)

plasma urea nitrogen amount [mmol/L] urea 114683 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Auwerx2

lipid profile

(none)

plasma cholesterol amount [mmol/L] chol 114685 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Auwerx2

lipid profile

(none)

plasma HDL amount [mmol/L] hdl 114687 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Auwerx2

lipid profile

(none)

plasma LDL amount [mmol/L] ldl 114689 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Auwerx2

lipid profile

(none)

plasma triglyceride amount [mmol/L] triglyc 114691 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Auwerx2

lipid profile

(none)

plasma free fatty acids amount [mmol/L] fatty_acids 114693 CD HFD

inbred w/CC8

9

both

21wks

N=4

2021

Benavides1

genotype assessment

(none)

Gpr84 allele deletion in exon 2 (0=yes, 1=no) [designation] Gpr84 48201

inbred w/CC8

58

both

6wks

2013

Bubier3

monitoring system

morphine

minimum respiratory depression (breath rate, percentage of baseline), post injection [%] min_depression 64901

inbred w/CC8

8

both

8-24wks

N=6

2019

Bubier3

monitoring system

morphine

time to recovery for mice that survived, post injection [h] recovery_time 64902

inbred w/CC8

8

both

8-24wks

N=3

2019

Bubier3

monitoring system

morphine

survival time for mice that did not survive, post injection [h] survival_time 64903

inbred w/CC8

8

both

8-24wks

N=4

2019

Bubier3

monitoring system

morphine

survival after 24h ( 0=dead, 1=alive), post injection [score] survival_24h 64904

inbred w/CC8

8

both

8-24wks

N=6

2019

CGDpheno1

complete blood count

(none)

white blood cell count (WBC; per volume x 10³) [n/µL] WBC 31801

inbred w/CC8

72

both

11wks

N=7

2009

CGDpheno1

complete blood count

(none)

red blood cell count (RBC; per volume x 10⁶) [n/µL] RBC 31802

inbred w/CC8

72

both

11wks

N=7

2009

CGDpheno1

complete blood count

(none)

neutrophil differential (NEUT; percentage of total WBC) [%] pctNEUT 31805

inbred w/CC8

72

both

11wks

N=7

2009

CGDpheno1

complete blood count

(none)

lymphocyte differential (LYM; percentage of total WBC) [%] pctLYMP 31806

inbred w/CC8

72

both

11wks

N=7

2009

CGDpheno1

complete blood count

(none)

monocyte differential (MONO; percentage of total WBC) [%] pctMONO 31807

inbred w/CC8

72

both

11wks

N=7

2009

CGDpheno1

complete blood count

(none)

eosinophil differential (EOS; percentage of total WBC) [%] pctEOS 31808

inbred w/CC8

72

both

11wks

N=7

2009

CGDpheno1

complete blood count

(none)

platelet count (PLT; units per volume x 10³) [n/µL] PLT 31820

inbred w/CC8

72

both

11wks

N=7

2009

CGDpheno1

complete blood count

(none)

mean platelet volume (MPV) [fL] MPV 31821

inbred w/CC8

72

both

11wks

N=7

2009

CGDpheno1

complete blood count

(none)

hematocrit (HCT) [%] HCT 31825

inbred w/CC8

72

both

11wks

N=7

2009

CGDpheno1

complete blood count

(none)

measured hemoglobin (HGB) [g/dL] mHGB 31826

inbred w/CC8

72

both

11wks

N=7

2009

CGDpheno1

complete blood count

(none)

mean RBC corpuscular volume (MCV) [fL] MCV 31827

inbred w/CC8

72

both

11wks

N=7

2009

CGDpheno1

complete blood count

(none)

mean RBC corpuscular hemoglobin content (MCH) [pg] MCH 31828

inbred w/CC8

72

both

11wks

N=7

2009

CGDpheno1

complete blood count

(none)

mean RBC corpuscular hemoglobin concentration (MCHC) [g/dL] MCHC 31829

inbred w/CC8

72

both

11wks

N=7

2009

CGDpheno1

complete blood count

(none)

RBC corpuscular distribution width (RDW) [%] RDW 31831

inbred w/CC8

72

both

11wks

N=7

2009

CGDpheno1

complete blood count

(none)

hemoglobin concentration distribution width (HDW) [g/dL] HDW 31832

inbred w/CC8

72

both

11wks

N=7

2009

CGDpheno1

complete blood count

(none)

reticulocyte differential (Retic; percentage of total RBC) [%] pct_Retic 31834

inbred w/CC8

72

both

11wks

N=7

2009

CGDpheno1

lipid profile

(none)

total cholesterol (plasma CHOL) [mg/dL] CHOL 31841

inbred w/CC8

72

both

12wks

N=7

2009

CGDpheno1

lipid profile

(none)

HDL cholesterol (plasma HDL) [mg/dL] HDLD 31842

inbred w/CC8

72

both

12wks

N=7

2009

CGDpheno1

lipid profile

(none)

triglycerides (plasma TG, 4h fast) [mg/dL] TG 31845

inbred w/CC8

72

both

12wks

N=7

2009

CGDpheno1

lipid profile

(none)

non-esterified free fatty acids (plasma NEFA, FFA) [mEq/L] NEFA 31848

inbred w/CC8

72

both

12wks

N=7

2009

CGDpheno1

metabolic panel

(none)

glucose (plasma GLU, 4h fast) [mg/dL] GLU 31850

inbred w/CC8

72

both

12wks

N=7

2009

CGDpheno1

metabolic panel

(none)

sodium (plasma Na) [mmol/L] sodium 31855

inbred w/CC8

72

both

12wks

N=8

2009

CGDpheno1

metabolic panel

(none)

potassium (plasma K) [mmol/L] potassium 31856

inbred w/CC8

72

both

12wks

N=8

2009

CGDpheno1

metabolic panel

(none)

chloride (plasma Cl) [mmol/L] chloride 31857

inbred w/CC8

72

both

12wks

N=8

2009

CGDpheno1

metabolic panel

(none)

total bilirubin (plasma TBIL) [µmol/L] TBIL 31860

inbred w/CC8

72

both

12wks

N=7

2009

CGDpheno1

metabolic panel

(none)

dissolved-ionized carbon dioxide (CO₂) [mmol/L] carbon_dioxide 31861

inbred w/CC8

72

both

12wks

N=8

2009

CGDpheno1

metabolic panel

(none)

blood urea nitrogen (BUN) [mg/dL] BUN 31862

inbred w/CC8

72

both

12wks

N=7

2009

CGDpheno1

metabolic panel

(none)

thyroxine (plasma T4) [µg/dL] T4 31870

inbred w/CC8

72

both

12wks

N=7

2009

CGDpheno3

metabolic panel

(none)

glucose (plasma GLU, 4h fast) [mg/dL] GLU 43901

CC diallel w/par

62

both

8wks

N=5

2012

CGDpheno3

lipid profile

(none)

total cholesterol (plasma CHOL) [mg/dL] CHOL 43902

CC diallel w/par

62

both

8wks

N=5

2012

CGDpheno3

lipid profile

(none)

HDL cholesterol (plasma HDL) [mg/dL] HDL 43903

CC diallel w/par

62

both

8wks

N=5

2012

CGDpheno3

lipid profile

(none)

triglycerides (plasma TG, 4h fast) [mg/dL] TG 43904

CC diallel w/par

62

both

8wks

N=5

2012

CGDpheno3

complete blood count

(none)

red blood cell count (RBC; per volume x 10⁶) [n/µL] RBC 43905

CC diallel w/par

62

both

7wks

N=5

2012

CGDpheno3

complete blood count

(none)

white blood cell count (WBC; per volume x 10³) [n/µL] WBC 43906

CC diallel w/par

62

both

7wks

N=5

2012

CGDpheno3

complete blood count

(none)

lymphocyte differential (LYM; percentage of total WBC) [%] pctLYMP 43907

CC diallel w/par

62

both

7wks

N=5

2012

CGDpheno3

complete blood count

(none)

neutrophil differential (NEUT; percentage of total WBC) [%] pctNEUT 43908

CC diallel w/par

62

both

7wks

N=5

2012

CGDpheno3

complete blood count

(none)

monocyte differential (MONO; percentage of total WBC) [%] pctMONO 43909

CC diallel w/par

62

both

7wks

N=5

2012

CGDpheno3

complete blood count

(none)

basophil differential (BASO; percentage of total WBC) [%] pctBASO 43910

CC diallel w/par

62

both

7wks

N=5

2012

CGDpheno3

complete blood count

(none)

eosinophil differential (EOS; percentage of total WBC) [%] pctEOS 43911

CC diallel w/par

62

both

7wks

N=5

2012

CGDpheno3

complete blood count

(none)

large unstained cells (LUC; percentage of total WBC) [%] pctLUC 43912

CC diallel w/par

62

both

7wks

N=5

2012

CGDpheno3

complete blood count

(none)

reticulocyte differential (Retic; percentage of total RBC) [%] pctRetic 43913

CC diallel w/par

62

both

7wks

N=5

2012

CGDpheno3

complete blood count

(none)

RBC corpuscular distribution width (RDW) [%] RDW 43914

CC diallel w/par

62

both

7wks

N=5

2012

CGDpheno3

complete blood count

(none)

mean RBC corpuscular volume (MCV) [fL] MCV 43915

CC diallel w/par

62

both

7wks

N=5

2012

CGDpheno3

complete blood count

(none)

mean RBC corpuscular hemoglobin conent (MCH) [pg] MCH 43916

CC diallel w/par

62

both

7wks

N=5

2012

CGDpheno3

complete blood count

(none)

mean RBC corpuscular hemoglobin concentration (MCHC) [g/dL] MCHC 43917

CC diallel w/par

62

both

7wks

N=5

2012

CGDpheno3

complete blood count

(none)

RBC corpuscular hemoglobin concentration mean (CHCM) [g/dL] CHCM 43918

CC diallel w/par

62

both

7wks

N=5

2012

CGDpheno3

complete blood count

(none)

hemoglobin concentration distribution width (HDW) [g/dL] HDW 43919

CC diallel w/par

62

both

7wks

N=5

2012

CGDpheno3

complete blood count

(none)

measured hemoglobin (HGB) [g/dL] mHGB 43920

CC diallel w/par

62

both

7wks

N=5

2012

CGDpheno3

complete blood count

(none)

calculated hemoglobin (HGB) [g/dL] cHGB 43921

CC diallel w/par

62

both

7wks

N=5

2012

CGDpheno3

complete blood count

(none)

hematocrit (HCT) [%] HCT 43922

CC diallel w/par

62

both

7wks

N=5

2012

CGDpheno3

complete blood count

(none)

platelet count (PLT; units per volume x 10³) [n/µL] PLT 43923

CC diallel w/par

62

both

7wks

N=5

2012

CGDpheno3

complete blood count

(none)

mean platelet volume (MPV) [fL] MPV 43924

CC diallel w/par

62

both

7wks

N=5

2012

CGDpheno3

tail cuff

(none)

systolic blood pressure [mmHg] systolic_BP 43925

CC diallel w/par

24

both

10wks

N=4

2012

CGDpheno3

tail cuff

(none)

pulse rate [n/min] pulse 43926

CC diallel w/par

24

both

10wks

N=4

2012

CGDpheno3

ECG

(none)

heart rate [n/min] HR 43927

CC diallel w/par

42

both

12wks

N=5

2012

CGDpheno3

ECG

(none)

coefficient of variance, heart rate [%] CV 43928

CC diallel w/par

42

both

12wks

N=5

2012

CGDpheno3

ECG

(none)

R-wave amplitude [mV] R_amplitude 43929

CC diallel w/par

42

both

12wks

N=5

2012

CGDpheno3

ECG

(none)

R plus S-wave amplitude [mV] RS_amplitude 43930

CC diallel w/par

42

both

12wks

N=5

2012

CGDpheno3

ECG

(none)

interval between R-waves (RR) [ms] RR 43931

CC diallel w/par

42

both

12wks

N=5

2012

CGDpheno3

ECG

(none)

interval between peak of P-wave to Q-wave (PQ) [ms] PQ 43932

CC diallel w/par

42

both

12wks

N=5

2012

CGDpheno3

ECG

(none)

interval between peak of P-wave to R-wave (PR) [ms] PR 43933

CC diallel w/par

42

both

12wks

N=5

2012

CGDpheno3

ECG

(none)

interval between beginning and end of QRS complex [ms] QRS 43934

CC diallel w/par

42

both

12wks

N=5

2012

CGDpheno3

ECG

(none)

interval between peak of Q-wave to end of T-wave (QT) [ms] QT 43935

CC diallel w/par

42

both

12wks

N=5

2012

CGDpheno3

ECG

(none)

rate-corrected QT interval [ms] QTc 43936

CC diallel w/par

42

both

12wks

N=5

2012

CGDpheno3

ECG

(none)

difference between smallest and largest QT interval [ms] QT_dispersion 43937

CC diallel w/par

42

both

12wks

N=5

2012

CGDpheno3

ECG

(none)

difference between smallest and largest rate-corrected QT interval [ms] QTc_dispersion 43938

CC diallel w/par

42

both

12wks

N=5

2012

CGDpheno3

ECG

(none)

interval between S-wave and end of T-wave (ST) [ms] ST 43939

CC diallel w/par

42

both

12wks

N=5

2012

CGDpheno3

DXA

(none)

whole body bone mineral density (BMD) [g/cm²] BMD 43940

CC diallel w/par

62

both

16wks

N=5

2012

CGDpheno3

DXA

(none)

whole body bone mineral content (BMC) [g] BMC 43941

CC diallel w/par

62

both

16wks

N=5

2012

CGDpheno3

DXA

(none)

whole body bone area, head excluded [cm²] bone_area 43942

CC diallel w/par

62

both

16wks

N=5

2012

CGDpheno3

DXA

(none)

total body area without head [cm²] total_area 43943

CC diallel w/par

62

both

16wks

N=5

2012

CGDpheno3

DXA

(none)

weight of lean tissue mass, head excluded [g] LTM 43944

CC diallel w/par

62

both

16wks

N=5

2012

CGDpheno3

DXA

(none)

percent fat, head excluded [%] pct_fat 43945

CC diallel w/par

62

both

16wks

N=5

2012

CGDpheno3

DXA

(none)

total tissue mass, head excluded [g] TTM 43946

CC diallel w/par

62

both

16wks

N=5

2012

CGDpheno3

body weight

(none)

body weight [g] bw 43947

CC diallel w/par

62

both

16wks

N=5

2012

Chesler2

metabolic panel

(none)

sodium (blood Na) [mmol/L] sodium 43401

CC diallel w/par

48

both

7-15wks

N=2

2011

Chesler2

metabolic panel

(none)

potassium (blood K) [mmol/L] potassium 43402

CC diallel w/par

48

both

7-15wks

N=2

2011

Chesler2

metabolic panel

(none)

chloride (blood Cl) [mmol/L] chloride 43403

CC diallel w/par

48

both

7-15wks

N=2

2011

Chesler2

metabolic panel

(none)

calcium (blood ionized Ca) [mmol/L] calcium 43404

CC diallel w/par

48

both

7-15wks

N=2

2011

Chesler2

metabolic panel

(none)

anion gap concentration (mEq/L) [mmol/L] anion_gap 43405

CC diallel w/par

48

both

7-15wks

N=2

2011

Chesler2

metabolic panel

(none)

carbon dioxide (blood CO₂) [mmol/L] carbon_dioxide 43406

CC diallel w/par

48

both

7-15wks

N=2

2011

Chesler2

metabolic panel

(none)

glucose (blood GLU, no fast) [mg/dL] GLU 43407

CC diallel w/par

47

both

7-15wks

N=2

2011

Chesler2

metabolic panel

(none)

glucose (blood GLU, 16h fast) [mg/dL] GLU_fast 43408

CC diallel w/par

47

both

7-15wks

N=3

2011

Chesler2

metabolic panel

(none)

blood urea nitrogen (BUN) [mg/dL] BUN 43409

CC diallel w/par

48

both

7-15wks

N=2

2011

Chesler2

metabolic panel

(none)

creatinine (blood) [mg/dL] creatinine 43410

CC diallel w/par

48

both

7-15wks

N=2

2011

Chesler2

complete blood count

(none)

white blood cell count (WBC; units per volume x 10³) [n/µL] WBC 43413

CC diallel w/par

48

both

7-15wks

N=2

2011

Chesler2

complete blood count

(none)

lymphocyte count (LYM; units per volume x 10³) [n/µL] LYM 43414

CC diallel w/par

48

both

7-15wks

N=2

2011

Chesler2

complete blood count

(none)

lymphocyte differential (LYM; percentage of viable WBC) [%] pct_LYM 43415

CC diallel w/par

48

both

7-15wks

N=2

2011

Chesler2

complete blood count

(none)

monocyte count (MONO; units per volume x 10³) [n/µL] MONO 43416

CC diallel w/par

48

both

7-15wks

N=2

2011

Chesler2

complete blood count

(none)

monocyte differential (MONO; percentage of viable WBC) [%] pct_MONO 43417

CC diallel w/par

48

both

7-15wks

N=2

2011

Chesler2

complete blood count

(none)

granulocyte count (GRA; units per volume x 10³) [n/µL] GRA 43418

CC diallel w/par

48

both

7-15wks

N=2

2011

Chesler2

complete blood count

(none)

granulocyte differential (GRA; percentage of total viable WBC) [%] pct_GRA 43419

CC diallel w/par

48

both

7-15wks

N=2

2011

Chesler2

complete blood count

(none)

eosinophil differential (EOS; percentage of viable WBC) [%] pct_EOS 43420

CC diallel w/par

48

both

7-15wks

N=2

2011

Chesler2

complete blood count

(none)

red blood cell count (RBC; units per volume x 10⁶) [n/µL] RBC 43421

CC diallel w/par

49

both

7-15wks

N=2

2011

Chesler2

complete blood count

(none)

mean RBC corpuscular volume (MCV) [fL] MCV 43422

CC diallel w/par

49

both

7-15wks

N=2

2011

Chesler2

complete blood count

(none)

RBC corpuscular distribution width (RDW) [%] RDW 43423

CC diallel w/par

49

both

7-15wks

N=2

2011

Chesler2

complete blood count

(none)

mean RBC corpuscular hemoglobin (MCH) [pg] MCH 43424

CC diallel w/par

49

both

7-15wks

N=2

2011

Chesler2

complete blood count

(none)

mean RBC corpuscular hemoglobin concentration (MCHC) [g/dL] MCHC 43425

CC diallel w/par

49

both

7-15wks

N=2

2011

Chesler2

complete blood count

(none)

hemoglobin (HGB) [g/dL] hemoglobin 43426

CC diallel w/par

49

both

7-15wks

N=2

2011

Chesler2

complete blood count

(none)

hematocrit (HCT) [%] hematocrit 43427

CC diallel w/par

49

both

7-15wks

N=2

2011

Chesler2

complete blood count

(none)

platelet count (PLT; units per volume x 10³) [n/µL] platelets 43428

CC diallel w/par

49

both

7-15wks

N=2

2011

Chesler2

complete blood count

(none)

mean platelet volume (MPV) [fL] MPV 43429

CC diallel w/par

49

both

7-15wks

N=2

2011

Chesler2

colony observation

(none)

number of mice born in first litter [n] litter_size 43441

CC diallel w/par

62

both

4wks

N=8

2011

Chesler2

colony observation

(none)

parental age at first litter [d] age_first_litter 43442

CC diallel w/par

62

both

4wks

N=8

2011

Chesler2

colony observation

(none)

time from mate to first litter [d] duration_to_litter 43443

CC diallel w/par

62

both

4wks

N=8

2011

Chesler2

open field test

(none)

distance traveled during first 3 min, 10 min test [cm] distance3_OFT 43451

CC diallel w/par

50

both

7-15wks

N=2

2011

Chesler2

open field test

(none)

distance traveled, 10 min test [cm] distance10_OFT 43452

CC diallel w/par

50

both

7-15wks

N=2

2011

Chesler2

open field test

(none)

number of transitions between center and periphery, 10 min test [n] transitions_OFT 43453

CC diallel w/par

50

both

7-15wks

N=2

2011

Chesler2

open field test

(none)

time spent in center during first minute, 10 min test [s] center1_OFT 43454

CC diallel w/par

50

both

7-15wks

N=2

2011

Chesler2

open field test

(none)

time spent in center, 10 min test [s] center10_OFT 43455

CC diallel w/par

50

both

7-15wks

N=2

2011

Chesler2

open field test

(none)

integrated distance from absolute center, 10 min test [cm] distance_center_OFT 43456

CC diallel w/par

50

both

7-15wks

N=2

2011

Chesler2

open field test

(none)

percentage of time in center, 10 min test [%] pct_center_OFT 43457

CC diallel w/par

50

both

7-15wks

N=2

2011

Chesler2

open field test

(none)

latency to reach periphery, 10 min test [s] latency_periphery_OFT 43458

CC diallel w/par

50

both

7-15wks

N=2

2011

Chesler2

open field test

(none)

time spent in periphery, 10 min test [s] duration_periphery_OFT 43459

CC diallel w/par

50

both

7-15wks

N=2

2011

Chesler2

open field test

(none)

time spent immobile during first minute, 10 min test [s] immobile_OFT 43460

CC diallel w/par

50

both

7-15wks

N=2

2011

Chesler2

open field test

(none)

number of fecal boli, 10 min test [n] fecal_boli_OFT 43461

CC diallel w/par

50

both

7-15wks

N=2

2011

Chesler2

open field test

(none)

number of urine puddles, 10 min test [n] urination_OFT 43462

CC diallel w/par

50

both

7-15wks

N=2

2011

Chesler2

light-dark box

(none)

time spent in light compartment, 10 min test [min] duration_light_LD 43463

CC diallel w/par

50

both

7-15wks

N=2

2011

Chesler2

light-dark box

(none)

distance traveled in light compartment, 10 min test [cm] distance_light_LD 43464

CC diallel w/par

50

both

7-15wks

N=2

2011

Chesler2

light-dark box

(none)

percentage of time in light compartment, 10 min test [%] pct_light_LD 43465

CC diallel w/par

50

both

7-15wks

N=2

2011

Chesler2

light-dark box

(none)

latency to enter dark compartment, 10 min test [s] latency_dark_LD 43466

CC diallel w/par

50

both

7-15wks

N=2

2011

Chesler2

light-dark box

(none)

number of transitions between light and dark compartments, 10 min test [n] transitions_LD 43467

CC diallel w/par

50

both

7-15wks

N=2

2011

Chesler2

light-dark box

(none)

number of fecal boli, 10 min test [n] fecal_boli_LD 43468

CC diallel w/par

50

both

7-15wks

N=2

2011

Chesler2

light-dark box

(none)

number of urine puddles, 10 min test [n] urination_LD 43469

CC diallel w/par

50

both

7-15wks

N=2

2011

Chesler2

behavior observation

(none)

response to capture [score] capture_score 43470

CC diallel w/par

62

both

7-15wks

N=8

2011

Chesler2

behavior observation

(none)

response to holding [score] hold_score 43471

CC diallel w/par

62

both

7-15wks

N=8

2011

Chesler2

behavior observation

(none)

capture and hold scores combined [score] wildness_score 43472

CC diallel w/par

62

both

7-15wks

N=8

2011

Chesler2

nociception assay

(none)

latency of nociceptive response to pressure on the tail, 60 s test [s] tail_clip 43473

CC diallel w/par

56

both

7-15wks

N=3

2011

Chesler2

nociception assay

(none)

latency of nociceptive response to hot plate (54°C), 30 s test [s] hot_plate 43474

CC diallel w/par

56

both

7-15wks

N=3

2011

Chesler2

monitoring system

(none)

percentage of time spent sleeping, baseline [%] pct_sleep_daily 43481

CC diallel w/par

57

both

7-15wks

N=3

2011

Chesler2

monitoring system

(none)

percentage of time spent sleeping during dark period, baseline [%] pct_sleep_dark 43482

CC diallel w/par

57

both

7-15wks

N=3

2011

Chesler2

monitoring system

(none)

percentage of time spent sleeping, following sleep deprivation [%] pct_daily_deprivation 43483

CC diallel w/par

57

both

7-15wks

N=2

2011

Chesler2

monitoring system

(none)

percentage of time spent sleeping during dark period, following sleep deprivation [%] pct_dark_deprivation 43484

CC diallel w/par

57

both

7-15wks

N=2

2011

Chesler2

monitoring system

(none)

peak activity time from dark onset, following sleep deprivation [h] act_dark_deprivation 43485

CC diallel w/par

57

both

7-15wks

N=2

2011

Chesler2

body size and weight

(none)

body weight [g] body_weight 43486

CC diallel w/par

56

both

7-15wks

N=3

2011

Chesler2

body size and weight

(none)

tail length [cm] tail_length 43488

CC diallel w/par

47

both

7-15wks

N=3

2011

Chesler2

fat pad weights

(none)

gonadal fat pad weight [g] gonad_fat_wt 43489

CC diallel w/par

46

both

7-15wks

N=3

2011

Chesler2

organ weights

(none)

heart weight [g] heart_wt 43492

CC diallel w/par

46

both

7-15wks

N=3

2011

Chesler2

organ weights

(none)

kidney (left) weight [g] kidneyL_wt 43496

CC diallel w/par

46

both

7-15wks

N=3

2011

Chesler3

metabolic panel

(none)

sodium (blood Na) [mmol/L] sodium 43501

CC pre w/par

190

both

7-15wks

N=1

2011

Chesler3

metabolic panel

(none)

potassium (blood K) [mmol/L] potassium 43502

CC pre w/par

190

both

7-15wks

N=1

2011

Chesler3

metabolic panel

(none)

chloride (blood Cl) [mmol/L] chloride 43503

CC pre w/par

190

both

7-15wks

N=1

2011

Chesler3

metabolic panel

(none)

calcium (blood ionized Ca) [mmol/L] calcium 43504

CC pre w/par

190

both

7-15wks

N=1

2011

Chesler3

metabolic panel

(none)

anion gap concentration (mEq/L) [mmol/L] anion_gap 43505

CC pre w/par

187

both

7-15wks

N=1

2011

Chesler3

metabolic panel

(none)

carbon dioxide (blood CO₂) [mmol/L] carbon_dioxide 43506

CC pre w/par

189

both

7-15wks

N=1

2011

Chesler3

metabolic panel

(none)

glucose (blood GLU, no fast) [mg/dL] GLU 43507

CC pre w/par

190

both

7-15wks

N=1

2011

Chesler3

metabolic panel

(none)

glucose (blood GLU, 16h fast) [mg/dL] GLU_fast 43508

CC pre w/par

275

both

7-15wks

N=2

2011

Chesler3

metabolic panel

(none)

blood urea nitrogen (BUN) [mg/dL] BUN 43509

CC pre w/par

190

both

7-15wks

N=1

2011

Chesler3

metabolic panel

(none)

creatinine (blood) [mg/dL] creatinine 43510

CC pre w/par

189

both

7-15wks

N=1

2011

Chesler3

complete blood count

(none)

white blood cell count (WBC; units per volume x 10³) [n/µL] WBC 43513

CC pre w/par

199

both

7-15wks

N=1

2011

Chesler3

complete blood count

(none)

lymphocyte count (LYM; units per volume x 10³) [n/µL] LYM 43514

CC pre w/par

198

both

7-15wks

N=1

2011

Chesler3

complete blood count

(none)

lymphocyte differential (LYM; percentage of viable WBC) [%] pct_LYM 43515

CC pre w/par

198

both

7-15wks

N=1

2011

Chesler3

complete blood count

(none)

monocyte count (MONO; units per volume x 10³) [n/µL] MONO 43516

CC pre w/par

198

both

7-15wks

N=1

2011

Chesler3

complete blood count

(none)

monocyte differential (MONO; percentage of viable WBC) [%] pct_MONO 43517

CC pre w/par

198

both

7-15wks

N=1

2011

Chesler3

complete blood count

(none)

granulocyte count (GRA; units per volume x 10³) [n/µL] GRA 43518

CC pre w/par

198

both

7-15wks

N=1

2011

Chesler3

complete blood count

(none)

granulocyte differential (GRA; percentage of total viable WBC) [%] pct_GRA 43519

CC pre w/par

198

both

7-15wks

N=1

2011

Chesler3

complete blood count

(none)

eosinophil differential (EOS; percentage of viable WBC) [%] pct_EOS 43520

CC pre w/par

198

both

7-15wks

N=1

2011

Chesler3

complete blood count

(none)

red blood cell count (RBC; units per volume x 10⁶) [n/µL] RBC 43521

CC pre w/par

200

both

7-15wks

N=1

2011

Chesler3

complete blood count

(none)

mean RBC corpuscular volume (MCV) [fL] MCV 43522

CC pre w/par

200

both

7-15wks

N=1

2011

Chesler3

complete blood count

(none)

RBC corpuscular distribution width (RDW) [%] RDW 43523

CC pre w/par

200

both

7-15wks

N=1

2011

Chesler3

complete blood count

(none)

mean RBC corpuscular hemoglobin (MCH) [pg] MCH 43524

CC pre w/par

200

both

7-15wks

N=1

2011

Chesler3

complete blood count

(none)

mean RBC corpuscular hemoglobin concentration (MCHC) [g/dL] MCHC 43525

CC pre w/par

200

both

7-15wks

N=1

2011

Chesler3

complete blood count

(none)

hemoglobin (HGB) [g/dL] hemoglobin 43526

CC pre w/par

200

both

7-15wks

N=1

2011

Chesler3

complete blood count

(none)

hematocrit (HCT) [%] hematocrit 43527

CC pre w/par

200

both

7-15wks

N=1

2011

Chesler3

complete blood count

(none)

platelet count (PLT; units per volume x 10³) [n/µL] platelets 43528

CC pre w/par

200

both

7-15wks

N=1

2011

Chesler3

complete blood count

(none)

mean platelet volume (MPV) [fL] MPV 43529

CC pre w/par

200

both

7-15wks

N=1

2011

Chesler3

organ weights

(none)

testicular weight [g] testes_wt 43540

CC pre w/par

54

both

4wks

N=1

2011

Chesler3

colony observation

(none)

number of mice born in first litter [n] litter_size 43541

CC pre w/par

312

both

4wks

N=2

2011

Chesler3

colony observation

(none)

parental age at first litter [d] age_first_litter 43542

CC pre w/par

312

both

4wks

N=2

2011

Chesler3

colony observation

(none)

time from mate to first litter [d] duration_to_litter 43543

CC pre w/par

312

both

4wks

N=2

2011

Chesler3

open field test

(none)

distance traveled during first 3 min, 10 min test [cm] distance3_OFT 43551

CC pre w/par

239

both

7-15wks

N=1

2011

Chesler3

open field test

(none)

distance traveled, 10 min test [cm] distance10_OFT 43552

CC pre w/par

239

both

7-15wks

N=1

2011

Chesler3

open field test

(none)

number of transitions between center and periphery, 10 min test [n] transitions_OFT 43553

CC pre w/par

235

both

7-15wks

N=1

2011

Chesler3

open field test

(none)

time spent in center during first minute, 10 min test [s] center1_OFT 43554

CC pre w/par

239

both

7-15wks

N=1

2011

Chesler3

open field test

(none)

time spent in center, 10 min test [s] center10_OFT 43555

CC pre w/par

239

both

7-15wks

N=1

2011

Chesler3

open field test

(none)

integrated distance from absolute center, 10 min test [cm] distance_center_OFT 43556

CC pre w/par

237

both

7-15wks

N=1

2011

Chesler3

open field test

(none)

percentage of time in center, 10 min test [%] pct_center_OFT 43557

CC pre w/par

239

both

7-15wks

N=1

2011

Chesler3

open field test

(none)

latency to reach periphery, 10 min test [s] latency_periphery_OFT 43558

CC pre w/par

235

both

7-15wks

N=1

2011

Chesler3

open field test

(none)

time spent in periphery, 10 min test [s] duration_periphery_OFT 43559

CC pre w/par

239

both

7-15wks

N=1

2011

Chesler3

open field test

(none)

time spent immobile during first minute, 10 min test [s] immobile_OFT 43560

CC pre w/par

237

both

7-15wks

N=1

2011

Chesler3

open field test

(none)

number of fecal boli, 10 min test [n] fecal_boli_OFT 43561

CC pre w/par

232

both

7-15wks

N=1

2011

Chesler3

open field test

(none)

number of urine puddles, 10 min test [n] urination_OFT 43562

CC pre w/par

232

both

7-15wks

N=1

2011

Chesler3

light-dark box

(none)

time spent in light compartment, 10 min test [s] duration_light_LD 43563

CC pre w/par

194

both

7-15wks

N=1

2011

Chesler3

light-dark box

(none)

distance traveled in light compartment, 10 min test [cm] distance_light_LD 43564

CC pre w/par

194

both

7-15wks

N=1

2011

Chesler3

light-dark box

(none)

percentage of time in light compartment, 10 min test [%] pct_light_LD 43565

CC pre w/par

196

both

7-15wks

N=1

2011

Chesler3

light-dark box

(none)

latency to enter dark compartment, 10 min test [s] latency_dark_LD 43566

CC pre w/par

199

both

7-15wks

N=1

2011

Chesler3

light-dark box

(none)

number of transitions between light and dark compartments, 10 min test [n] transitions_LD 43567

CC pre w/par

196

both

7-15wks

N=1

2011

Chesler3

light-dark box

(none)

number of fecal boli, 10 min test [n] fecal_boli_LD 43568

CC pre w/par

193

both

7-15wks

N=1

2011

Chesler3

light-dark box

(none)

number of urine puddles, 10 min test [n] urination_LD 43569

CC pre w/par

193

both

7-15wks

N=1

2011

Chesler3

behavior observation

(none)

response to capture [score] capture_score 43570

CC pre w/par

350

both

7-15wks

N=2

2011

Chesler3

behavior observation

(none)

response to holding [score] hold_score 43571

CC pre w/par

350

both

7-15wks

N=2

2011

Chesler3

behavior observation

(none)

capture and hold scores combined [score] wildness_score 43572

CC pre w/par

350

both

7-15wks

N=2

2011

Chesler3

nociception assay

(none)

latency of nociceptive response to pressure on the tail, 60 s test [s] tail_clip 43573

CC pre w/par

330

both

7-15wks

N=2

2011

Chesler3

nociception assay

(none)

latency of nociceptive response to hot plate (54°C), 30 s test [s] hot_plate 43574

CC pre w/par

329

both

7-15wks

N=2

2011

Chesler3

monitoring system

(none)

percentage of time sleeping, baseline [%] pct_sleep 43581 total dark period

CC pre w/par

301

both

7-15wks

N=2

2011

Chesler3

monitoring system

(none)

percentage of time sleeping, after sleep deprivation [%] deprivation 43583 total dark period peak activity

CC pre w/par

301

both

7-15wks

N=2

2011

Chesler3

body size and weight

(none)

body weight [g] body_weight 43586

CC pre w/par

362

both

7-15wks

N=3

2011

Chesler3

body size and weight

(none)

body length [cm] body_length 43587

CC pre w/par

279

both

7-15wks

N=2

2011

Chesler3

body size and weight

(none)

tail length [cm] tail_length 43588

CC pre w/par

352

both

7-15wks

N=2

2011

Chesler3

fat pad weights

(none)

gonadal fat pad weight [g] gonad_fat_wt 43589

CC pre w/par

350

both

7-15wks

N=2

2011

Chesler3

bone dimensions

(none)

periosteal (outer) circumference, femoral mid-diaphysis [mm] bone_circumference 43590

CC pre w/par

235

both

7-15wks

N=1

2011

Chesler3

organ weights

(none)

brain weight [g] brain_wt 43591

CC pre w/par

181

both

7-15wks

N=1

2011

Chesler3

organ weights

(none)

heart weight [g] heart_wt 43592

CC pre w/par

352

both

7-15wks

N=2

2011

Chesler3

organ dimensions

(none)

kidney length [cm] kidney_length 43593 left right

CC pre w/par

124

both

7-15wks

N=1

2011

Chesler3

organ dimensions

(none)

kidney volume [cm³] kidney_vol 43595

CC pre w/par

77

both

7-15wks

N=1

2011

Chesler3

organ weights

(none)

kidney weight [g] kidney_wt 43596 left right both

CC pre w/par

351

both

7-15wks

N=2

2011

Chesler3

organ weights

(none)

spleen weight [g] spleen_wt 43599

CC pre w/par

263

both

7-15wks

N=2

2011

Chesler4

open field test

(none)

distance traveled in first 4 min, response to novelty, 20 min test [cm] OF_distance_first4 47001

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

open field test

(none)

total distance traveled, 20 min test [cm] OF_distance 47002

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

open field test

(none)

percentage of time in corners, 20 min test [%] OF_corner_pct 47003

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

open field test

(none)

percentage of time in periphery, 20 min test [%] OF_periphery_pct 47004

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

open field test

(none)

percentage of time immobile, 20 min test [%] OF_immobile_pct 47005

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

open field test

(none)

percentage of time in center, 20 min test [%] OF_center_pct 47006

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

light-dark box

(none)

distance traveled in light compartment, 20 min test [cm] LD_distance_light 47007

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

light-dark box

(none)

number of light-dark transitions, 20 min test [n] LD_transitions 47008

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

light-dark box

(none)

time in light compartment first 4 min, response to novelty, 20 min test [s] LD_light_first4 47009

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

light-dark box

(none)

percentage of time in light compartment, 20 min test [%] LD_light_pct 47010

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

visual cliff

(none)

distance traveled in top during first 4 min, response to novelty, 20 min test [cm] VC_top_distance_first4 47011

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

visual cliff

(none)

time in top during first 4 min, response to novelty, 20 min test [s] VC_top_time_first4 47012

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

visual cliff

(none)

total distance traveled in top, 20 min test [cm] VC_top_distance 47013

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

visual cliff

(none)

percentage of time in top, 20 min test [%] VC_top_time_pct 47014

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

visual cliff

(none)

mean velocity in top, 20 min test [cm/s] VC_top_velocity 47015

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

visual cliff

(none)

distance traveled in bottom during first 4 min (response to novelty), 20 min test [cm] VC_bottom_distance_first4 47016

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

visual cliff

(none)

time in bottom during first 4 min, response to novelty, 20 min test [s] VC_bottom_time_first4 47017

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

visual cliff

(none)

total distance traveled in bottom, 20 min test [cm] VC_bottom_distance 47018

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

visual cliff

(none)

percentage of time in bottom, 20 min test [%] VC_bottom_time_pct 47020

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

visual cliff

(none)

mean velocity in bottom, 20 min test [cm/s] VC_bottom_velocity 47021

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

visual cliff

(none)

number of top to bottom transitions, 20 min test [n] VC_bottom_transitions 47022

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

nociception assay

(none)

latency of hindpaw withdrawal, 55°C heat stimulation [s] HP_latency 47024

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

tail suspension test

(none)

average frequency climbing, 5 min test [n] TS_frequency_climbing 47026

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

tail suspension test

(none)

average time immobile, 5 min test [s] TS_time_immobile 47027

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

tail suspension test

(none)

average latency to first immobility episode, 5 min test [s] TS_latency_immobile 47028

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

body weight

(none)

body weight at dissection [g] bw 47029

DO population w/par

9

both

12-16wks

N=8

2013

Collins1

complete blood count

(none)

red blood cell count (RBC; per volume x 10⁶) [n/µL] RBC 45101

CC pre w/par

139

m

10-14wks

N=1

2012

Collins1

complete blood count

(none)

white blood cell count (WBC; per volume x 10³) [n/µL] WBC 45102

CC pre w/par

138

m

10-14wks

N=1

2012

Collins1

complete blood count

(none)

lymphocyte count (LYM; per volume x 10³) [n/µL] LYM 45103

CC pre w/par

138

m

10-14wks

N=1

2012

Collins1

complete blood count

(none)

lymphocyte differential (LYM; percentage of total WBC) [%] LYM_pct 45104

CC pre w/par

138

m

10-14wks

N=1

2012

Collins1

complete blood count

(none)

neutrophil count (NEUT; per volume x 10³) [n/µL] NEUT 45105

CC pre w/par

138

m

10-14wks

N=1

2012

Collins1

complete blood count

(none)

neutrophil differential (NEUT; percentage of total WBC) [%] NEUT_pct 45106

CC pre w/par

138

m

10-14wks

N=1

2012

Collins1

complete blood count

(none)

monocyte count (MONO; per volume x 10³) [n/µL] MONO 45107

CC pre w/par

138

m

10-14wks

N=1

2012

Collins1

complete blood count

(none)

monocyte differential (MONO; percentage of total WBC) [%] MONO_pct 45108

CC pre w/par

138

m

10-14wks

N=1

2012

Collins1

complete blood count

(none)

eosinophil count (EOS; per volume x 10³) [n/µL] EOS 45109

CC pre w/par

138

m

10-14wks

N=1

2012

Collins1

complete blood count

(none)

eosinophil differential (EOS; percentage of total WBC) [%] EOS_pct 45110

CC pre w/par

138

m

10-14wks

N=1

2012

Collins1

complete blood count

(none)

basophil count (BASO; per volume x 10³) [n/µL] BASO 45111

CC pre w/par

138

m

10-14wks

N=1

2012

Collins1

complete blood count

(none)

basophil differential (BASO; percentage of total WBC) [%] BASO_pct 45112

CC pre w/par

138

m

10-14wks

N=1

2012

Collins1

complete blood count

(none)

RBC corpuscular distribution width (RDW) [%] RDW 45113

CC pre w/par

139

m

10-14wks

N=1

2012

Collins1

complete blood count

(none)

mean RBC corpuscular volume (MCV) [fL] MCV 45114

CC pre w/par

139

m

10-14wks

N=1

2012

Collins1

complete blood count

(none)

hemoglobin (HGB) [g/dL] HGB 45115

CC pre w/par

139

m

10-14wks

N=1

2012

Collins1

complete blood count

(none)

platelet count (PLT; per volume x 10³) [n/µL] PLT 45116

CC pre w/par

139

m

10-14wks

N=1

2012

Collins1

complete blood count

(none)

mean platelet volume (MPV) [fL] MPV 45117

CC pre w/par

139

m

10-14wks

N=1

2012

Crowley1

body weight

haloperidol

body weight [g] bw 39401 starting ending

inbred w/CC8

27

m

9-28wks

N=6

2012

Crowley1

drug and metabolite quantification

haloperidol

plasma haloperidol concentration [nM] haloperidol 39403 day: 30 60 90 120

inbred w/CC8

27

m

9-28wks

N=6

2012

Crowley1

inclined screen test

haloperidol

latency to move four paws, extrapyramidal side effects [s] latency 39407 day: 0 3 7 30 60 120

inbred w/CC8

27

m

9-28wks

N=6

2012

Crowley1

open field test

haloperidol

distance traveled, 60 min test [cm] horizontal_act 39412 day: 0 30 60 120

inbred w/CC8

27

m

9-28wks

N=6

2012

Crowley1

open field test

haloperidol

vertical activity, beam breaks, 60 min test [n] vertical_act 39417 day: 0 30 60 120

inbred w/CC8

27

m

9-28wks

N=6

2012

Crowley1

open field test

haloperidol

repetitive behavior, breaking of same beam, 60 min test [n] stereotypy 39421 day: 0 30 60 120

inbred w/CC8

27

m

9-28wks

N=6

2012

Crowley1

open field test

haloperidol

center occupancy, percentage of total time [%] pct_center 39425 day: 0 30 60 120

inbred w/CC8

27

m

9-28wks

N=6

2012

Crowley1

behavior observation

haloperidol

tongue protrusions, 15 min test [n] tongue 39429 day: 0 30 60 120

inbred w/CC8

27

m

9-28wks

N=6

2012

Crowley1

behavior observation

haloperidol

overt chewing movements, 15 min test [n] overtchew 39433 day: 0 30 60 120

inbred w/CC8

27

m

9-28wks

N=6

2012

Crowley1

behavior observation

haloperidol

subtle chewing movements, 15 min test [n] subtlechew 39437 day: 0 30 60 120

inbred w/CC8

27

m

9-28wks

N=6

2012

Crowley1

behavior observation

haloperidol

jaw tremor duration, 15 min test [s] jawtremor 39441 day: 0 30 60 120

inbred w/CC8

27

m

9-28wks

N=6

2012

CSNA03

open field test

(none)

total distance traveled, 60 min test (OFT), founders [cm] dist_OFT_in 90001

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

total distance traveled, 60 min test (OFT), CC [cm] dist_OFT_cc 90002

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

distance traveled in perimeter and corners, 60 min test (OFT), founders [cm] dist_perimeter_corners_OFT_in 90004

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

distance traveled in perimeter and corners, 60 min test (OFT), CC [cm] dist_perimeter_corners_OFT_cc 90005

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

distance traveled in perimeter and corners, 60 min test (OFT), DO [cm] dist_perimeter_corners_OFT_do 90006

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

distance traveled in perimeter, 60 min test (OFT), founders [cm] dist_perimeter_OFT_in 90007

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

distance traveled in perimeter, 60 min test (OFT), CC [cm] dist_perimeter_OFT_cc 90008

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

distance traveled in perimeter, 60 min test (OFT), DO [cm] dist_perimeter_OFT_do 90009

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

distance traveled in corners, 60 min test (OFT), founders [cm] dist_corners_OFT_in 90010

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

distance traveled in corners, 60 min test (OFT), CC [cm] dist_corners_OFT_cc 90011

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

distance traveled in corners, 60 min test (OFT), DO [cm] dist_corners_OFT_do 90012

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

percentage of total distance traveled in center, 60 min test (OFT), founders [%] pct_dist_center_OFT_in 90013

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

percentage of total distance traveled in center, 60 min test (OFT), CC [%] pct_dist_center_OFT_cc 90014

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

percentage of total distance traveled in center, 60 min test (OFT), DO [%] pct_dist_center_OFT_do 90015

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

distance traveled slope, 60 min test (OFT), founders dist_slope_OFT_in 90016

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

distance traveled slope, 60 min test (OFT), CC dist_slope_OFT_cc 90017

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

distance traveled slope, 60 min test (OFT), DO dist_slope_OFT_do 90018

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

distance traveled in successive 5 min intervals, 60 min test (OFT), founders [cm] amb_dist_OFT_in 90019 min: 0-5 5-10 10-15 15-20 20-25 25-30 30-35 35-40 40-45 45-50 50-55 55-60

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

distance traveled in successive 5 min intervals, 60 min test (OFT), CC [cm] amb_dist_OFT_cc 90020 min: 0-5 5-10 10-15 15-20 20-25 25-30 30-35 35-40 40-45 45-50 50-55 55-60

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

distance traveled in successive 5 min intervals, 60 min test (OFT), DO [cm] amb_dist_OFT_do 90021 min: 0-5 5-10 10-15 15-20 20-25 25-30 30-35 35-40 40-45 45-50 50-55 55-60

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

habituation ratio (first:last intervals), 60 min test (OFT), founders [ratio] habituation_OFT_in 90055

inbred w/CC8

10

both

4-14wks

N=35

2018

CSNA03

open field test

(none)

habituation ratio (first:last intervals), 60 min test (OFT), CC [ratio] habituation_OFT_cc 90056

CC w/par

59

both

4-19wks

N=15

2018

CSNA03

open field test

(none)

time in perimeter and corners, 60 min test (OFT), founders [s] time_perimeter_corners_OFT_in 90100

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

time in perimeter and corners, 60 min test (OFT), CC [s] time_perimeter_corners_OFT_cc 90101

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

time in perimeter and corners, 60 min test (OFT), DO [s] time_perimeter_corners_OFT_do 90102

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

time in perimeter, 60 min test (OFT), founders [s] time_perimeter_OFT_in 90103

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

time in perimeter, 60 min test (OFT), CC [s] time_perimeter_OFT_cc 90104

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

time in perimeter, 60 min test (OFT), DO [s] time_perimeter_OFT_do 90105

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

time in corners, 60 min test (OFT), founders [s] time_corner_OFT_in 90106

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

time in corners, 60 min test (OFT), CC [s] time_corner_OFT_cc 90107

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

time in corners, 60 min test (OFT), DO [s] time_corner_OFT_do 90108

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

percentage of total time spent in center, 60 min test (OFT), founders [%] pct_center_time_OFT_in 90109

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

percentage of total time spent in center, 60 min test (OFT), CC [%] pct_center_time_OFT_cc 90110

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

percentage of total time spent in center, 60 min test (OFT), DO [%] pct_center_time_OFT_do 90111

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

percentage of total distance traveled in perimeter and corners, 60 min test (OFT), founders [%] pct_dist_perimeter_corners_OFT_in 90112

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

percentage of total distance traveled in perimeter and corners, 60 min test (OFT), CC [%] pct_dist_perimeter_corners_OFT_cc 90113

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

percentage of total distance traveled in perimeter and corners, 60 min test (OFT), DO [%] pct_dist_perimeter_corners_OFT_do 90114

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

percentage of total distance traveled in perimeter, 60 min test (OFT), founders [%] pct_dist_perimeter_OFT_in 90115

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

percentage of total distance traveled in perimeter, 60 min test (OFT), CC [%] pct_dist_perimeter_OFT_cc 90116

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

percentage of total distance traveled in perimeter, 60 min test (OFT), DO [%] pct_dist_perimeter_OFT_do 90117

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

percentage of total time spent in perimeter and corners, 60 min test (OFT), founders [%] pct_time_perimeter_corner_OFT_in 90118

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

percentage of total time spent in perimeter and corners, 60 min test (OFT), CC [%] pct_time_perimeter_corner_OFT_cc 90119

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

percentage of total time spent in perimeter and corners, 60 min test (OFT), DO [%] pct_time_perimeter_corner_OFT_do 90120

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

percentage of total time spent in perimeter, 60 min test (OFT), founders [%] pct_time_perimeter_OFT_in 90121

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

percentage of total time spent in perimeter, 60 min test (OFT), CC [%] pct_time_perimeter_OFT_cc 90122

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

percentage of total time spent in perimeter, 60 min test (OFT), DO [%] pct_time_perimeter_OFT_do 90123

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

time in center, 60 min test (OFT), founders [s] center_time_OFT_in 90124

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

time in center, 60 min test (OFT), CC [s] center_time_OFT_cc 90125

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

distance traveled in center, 60 min test (OFT), founders [cm] center_dist_OFT_in 90127

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

distance traveled in center, 60 min test (OFT), CC [cm] center_dist_OFT_cc 90128

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

total distance traveled, 20 min test (LD box), founders [cm] dist_LD_in 90130

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

total distance traveled, 20 min test (LD box), CC [cm] dist_LD_cc 90131

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

total distance traveled, 20 min test (LD box), DO [cm] dist_LD_do 90132

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

distance traveled in light, 20 min test (LD box), founders [cm] dist_light_LD_in 90133

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

distance traveled in light, 20 min test (LD box), CC [cm] dist_light_LD_cc 90134

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

distance traveled in light, 20 min test (LD box), DO [cm] dist_light_LD_do 90135

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

distance traveled in dark, 20 min test (LD box), founders [cm] dist_dark_LD_in 90136

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

distance traveled in dark, 20 min test (LD box), CC [cm] dist_dark_LD_cc 90137

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

distance traveled in dark, 20 min test (LD box), DO [cm] dist_dark_LD_do 90138

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

percentage of total distance traveled in light, 20 min test (LD box), founders [%] pct_dist_light_LD_in 90139

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

percentage of total distance traveled in light, 20 min test (LD box), CC [%] pct_dist_light_LD_cc 90140

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

percentage of total distance traveled in light, 20 min test (LD box), DO [%] pct_dist_light_LD_do 90141

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

total ambulatory time, 20 min test (LD box), founders [s] amb_time_tot_LD_in 90142

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

total ambulatory time, 20 min test (LD box), CC [s] amb_time_tot_LD_cc 90143

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

total ambulatory time, 20 min test (LD box), DO [s] amb_time_tot_LD_do 90144

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

ambulatory time in light, 20 min test (LD box), founders [s] amb_time_light_LD_in 90145

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

ambulatory time in light, 20 min test (LD box), CC [s] amb_time_light_LD_cc 90146

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

ambulatory time in light, 20 min test (LD box), DO [s] amb_time_light_LD_do 90147

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

ambulatory time in dark, 20 min test (LD box), founders [s] amb_time_dark_LD_in 90148

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

ambulatory time in dark, 20 min test (LD box), CC [s] amb_time_dark_LD_cc 90149

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

ambulatory time in dark, 20 min test (LD box), DO [s] amb_time_dark_LD_do 90150

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

percentage of time spent ambulatory in light, 20 min test (LD box), founders [%] pct_amb_time_light_LD_in 90151

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

percentage of time spent ambulatory in light, 20 min test (LD box), CC [%] pct_amb_time_light_LD_cc 90152

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

percentage of time spent ambulatory in light, 20 min test (LD box), DO [%] pct_amb_time_light_LD_do 90153

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

percentage of time resting in light, 20 min test (LD box), founders [%] pct_rest_time_light_LD_in 90163

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

percentage of time resting in light, 20 min test (LD box), CC [%] pct_rest_time_light_LD_cc 90164

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

percentage of time resting in light, 20 min test (LD box), DO [%] pct_rest_time_light_LD_do 90165

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

total time, 20 min test (LD box), founders [s] time_tot_LD_in 90202

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

total time, 20 min test (LD box), CC [s] time_tot_LD_cc 90203

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

total time, 20 min test (LD box), DO [s] time_tot_LD_do 90204

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

time in light, 20 min test (LD box), founders [s] time_light_LD_in 90205

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

time in light, 20 min test (LD box), CC [s] time_light_LD_cc 90206

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

time in dark, 20 min test (LD box), founders [s] time_dark_LD_in 90208

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

time in dark, 20 min test (LD box), CC [s] time_dark_LD_cc 90209

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

time in dark, 20 min test (LD box), DO [s] time_dark_LD_do 90210

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

percentage of time in light, 20 min test (LD box), founders [%] pct_time_light_LD_in 90211

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

percentage of time in light, 20 min test (LD box), CC [%] pct_time_light_LD_cc 90212

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

percentage of time in light, 20 min test (LD box), DO [%] pct_time_light_LD_do 90213

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

total ambulatory counts, 20 min test (LD box), founders [n] amb_counts_tot_LD_in 90214

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

total ambulatory counts, 20 min test (LD box), CC [n] amb_counts_tot_LD_cc 90215

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

total ambulatory counts, 20 min test (LD box), DO [n] amb_counts_tot_LD_do 90216

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

ambulatory counts in light, 20 min test (LD box), founders [n] amb_counts_light_LD_in 90217

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

ambulatory counts in light, 20 min test (LD box), CC [n] amb_counts_light_LD_cc 90218

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

ambulatory counts in light, 20 min test (LD box), DO [n] amb_counts_light_LD_do 90219

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

ambulatory counts in dark, 20 min test (LD box), founders [n] amb_counts_dark_LD_in 90220

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

ambulatory counts in dark, 20 min test (LD box), CC [n] amb_counts_dark_LD_cc 90221

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

ambulatory counts in dark, 20 min test (LD box), DO [n] amb_counts_dark_LD_do 90222

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

percentage of ambulatory counts in light, 20 min test (LD box), founders [%] pct_amb_counts_light_LD_in 90223

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

percentage of ambulatory counts in light, 20 min test (LD box), CC [%] pct_amb_counts_light_LD_cc 90224

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

percentage of ambulatory counts in light, 20 min test (LD box), DO [%] pct_amb_counts_light_LD_do 90225

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

total number of light-dark transitions, 20 min test (LD box), founders [n] light_dark_transitions_LD_in 90262

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

total number of light-dark transitions, 20 min test (LD box), CC [n] light_dark_transitions_LD_cc 90263

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

total number of light-dark transitions, 20 min test (LD box), DO [n] light_dark_transitions_LD_do 90264

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

hole board test

(none)

total number of entries (hole board), founders [n] entries_total_HB_in 90265

inbred w/CC8

10

both

4-13wks

N=40

2018

CSNA03

hole board test

(none)

total number of entries (hole board), CC [n] entries_total_HB_cc 90266

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

hole board test

(none)

total number of entries (hole board), DO [n] entries_total_HB_do 90267

DO population w/par

9

both

4-25wks

N=193

2018

CSNA03

hole board test

(none)

number of novel entries (hole board), founders [n] entries_novel_HB_in 90268

inbred w/CC8

10

both

4-13wks

N=40

2018

CSNA03

hole board test

(none)

number of novel entries (hole board), CC [n] entries_novel_HB_cc 90269

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

hole board test

(none)

number of novel entries (hole board), DO [n] entries_novel_HB_do 90270

DO population w/par

9

both

4-25wks

N=193

2018

CSNA03

hole board test

(none)

number of repeat entries (hole board), founders [n] entries_repeat_HB_in 90271

inbred w/CC8

10

both

4-13wks

N=40

2018

CSNA03

hole board test

(none)

number of repeat entries (hole board), CC [n] entries_repeat_HB_cc 90272

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

hole board test

(none)

number of repeat entries (hole board), DO [n] entries_repeat_HB_do 90273

DO population w/par

9

both

4-25wks

N=193

2018

CSNA03

conditioned place preference test

(none)

percentage of time spent in novel zone, excluding center gray zone (novelty preference), founders [%] time_wo_gray_in 90286

inbred w/CC8

10

both

12wks

N=40

2018

CSNA03

conditioned place preference test

(none)

percentage of time spent in novel zone, excluding center gray zone (novelty preference), CC [%] time_wo_gray_cc 90287

CC w/par

59

both

6-14wks

N=17

2018

CSNA03

conditioned place preference test

(none)

percentage of time spent in novel zone, excluding center gray zone (novelty preference), DO [%] time_wo_gray_do 90288

DO population w/par

9

both

8-25wks

N=190

2018

CSNA03

conditioned place preference test

(none)

percentage of time spent in novel zone, including center gray zone (novelty preference), founders [%] time_w_gray_in 90289

inbred w/CC8

10

both

12wks

N=40

2018

CSNA03

conditioned place preference test

(none)

percentage of time spent in novel zone, including center gray zone (novelty preference), CC [%] time_w_gray_cc 90290

CC w/par

59

both

6-14wks

N=17

2018

CSNA03

conditioned place preference test

(none)

percentage of time spent in novel zone, including center gray zone (novelty preference), DO [%] time_w_gray_do 90291

DO population w/par

9

both

8-25wks

N=190

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 3 minus Day 2, saline control, founders [cm] dist_d3_d2_cont_in 90304

inbred w/CC8

9

both

8-14wks

N=6

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 3 minus Day 2, saline control, CC [cm] dist_d3_d2_cont_cc 90305

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 3 minus Day 2, saline control, DO [cm] dist_d3_d2_cont_do 90306

DO population w/par

9

both

8-21wks

N=26

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 3 (cocaine) minus Day 2 (saline), cocaine sensitization, founders [cm] dist_d3_d2_cocaine_in 90307

inbred w/CC8

10

both

8-14wks

N=6

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 3 (cocaine) minus Day 2 (saline), cocaine sensitization, CC [cm] dist_d3_d2_cocaine_cc 90308

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 3 (cocaine) minus Day 2 (saline), cocaine sensitization, DO [cm] dist_d3_d2_cocaine_do 90309

DO population w/par

9

both

8-21wks

N=27

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 5 minus Day 3, saline control, founders [cm] dist_d5_d3_cont_in 90310

inbred w/CC8

9

both

8-14wks

N=6

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 5 minus Day 3, saline control, CC [cm] dist_d5_d3_cont_cc 90311

CC w/par

58

both

8-21wks

N=3

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 5 minus Day 3, saline control, DO [cm] dist_d5_d3_cont_do 90312

DO population w/par

9

both

8-21wks

N=26

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 5 (cocaine) minus Day 3 (cocaine), cocaine sensitization, founders [cm] dist_d5_d3_cocaine_in 90313

inbred w/CC8

10

both

8-14wks

N=6

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 5 (cocaine) minus Day 3 (cocaine), cocaine sensitization, CC [cm] dist_d5_d3_cocaine_cc 90314

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 5 (cocaine) minus Day 3 (cocaine), cocaine sensitization, DO [cm] dist_d5_d3_cocaine_do 90315

DO population w/par

9

both

8-21wks

N=27

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 12 minus Day 2, saline control, founders [cm] dist_d12_d2_cont_in 90316

inbred w/CC8

9

both

8-14wks

N=6

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 12 minus Day 2, saline control, CC [cm] dist_d12_d2_cont_cc 90317

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 12 minus Day 2, saline control, DO [cm] dist_d12_d2_cont_do 90318

DO population w/par

9

both

8-21wks

N=26

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 12 (saline) minus Day 2 (saline), cocaine sensitization, founders [cm] dist_d12_d2_cocaine_in 90319

inbred w/CC8

10

both

8-14wks

N=6

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 12 (saline) minus Day 2 (saline), cocaine sensitization, CC [cm] dist_d12_d2_cocaine_cc 90320

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 12 (saline) minus Day 2 (saline), cocaine sensitization, DO [cm] dist_d12_d2_cocaine_do 90321

DO population w/par

9

both

8-21wks

N=27

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 19 minus Day 11, saline control, founders [cm] dist_d19_d11_cont_in 90322

inbred w/CC8

9

both

8-14wks

N=7

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 19 minus Day 11, saline control, CC [cm] dist_d19_d11_cont_cc 90323

CC w/par

58

both

8-21wks

N=3

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 19 minus Day 11, saline control, DO [cm] dist_d19_d11_cont_do 90324

DO population w/par

9

both

8-21wks

N=22

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 19 (cocaine) minus Day 11 (cocaine), cocaine sensitization, founders [cm] dist_d19_d11_cocaine_in 90325

inbred w/CC8

10

both

8-14wks

N=6

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 19 (cocaine) minus Day 11 (cocaine), cocaine sensitization, CC [cm] dist_d19_d11_cocaine_cc 90326

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 19 (cocaine) minus Day 11 (cocaine), cocaine sensitization, DO [cm] dist_d19_d11_cocaine_do 90327

DO population w/par

9

both

8-21wks

N=23

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 3 to Day 11 AUC, saline control, founders dist_d3_d11_auc_cont_in 90437

inbred w/CC8

9

both

8-14wks

N=6

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 3 to Day 11 AUC, saline control, CC dist_d3_d11_auc_cont_cc 90438

CC w/par

58

both

8-21wks

N=3

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 3 to Day 11 AUC, saline control, DO dist_d3_d11_auc_cont_do 90439

DO population w/par

9

both

8-21wks

N=21

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 3 (cocaine) to Day 11 (cocaine) AUC, cocaine sensitization, founders dist_d3_d11_auc_cocaine_in 90440

inbred w/CC8

10

both

8-14wks

N=6

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 3 (cocaine) to Day 11 (cocaine) AUC, cocaine sensitization, CC dist_d3_d11_auc_cocaine_cc 90441

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 3 (cocaine) to Day 11 (cocaine) AUC, cocaine sensitization, DO dist_d3_d11_auc_cocaine_do 90442

DO population w/par

9

both

8-21wks

N=21

2018

CSNA03

open field test

(none)

distance traveled, first 30 min (pre-injection), on successive days, saline group, founders [cm] dist_f30_cont_in 90328 day: 1 2 3 5 7 9 11 12 19

inbred w/CC8

9

both

8-14wks

N=7

2018

CSNA03

open field test

(none)

distance traveled, first 30 min (pre-injection), on successive days, saline group, CC [cm] dist_f30_cont_cc 90329 day: 1 2 3 5 7 9 11 12 19

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

(none)

distance traveled, first 30 min (pre-injection), on successive days, saline group, DO [cm] dist_f30_cont_do 90330 day: 1 2 3 5 7 9 11 12 19

DO population w/par

9

both

8-21wks

N=26

2018

CSNA03

open field test

cocaine

distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders [cm] dist_f30_cocaine_in 90331 day: 1 2 3 5 7 9 11 12 19

inbred w/CC8

10

both

8-14wks

N=6

2018

CSNA03

open field test

cocaine

distance traveled, first 30 min (pre-injection), on successive days, cocaine group, CC [cm] dist_f30_cocaine_cc 90332 day: 1 2 3 5 7 9 11 12 19

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

cocaine

distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO [cm] dist_f30_cocaine_do 90333 day: 1 2 3 5 7 9 11 12 19

DO population w/par

9

both

8-21wks

N=27

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), on successive days, saline control, founders [cm] dist_l60_cont_in 90382 day: 1 2 3 5 7 9 11 12 19

inbred w/CC8

9

both

8-14wks

N=7

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), on successive days, saline control, CC [cm] dist_l60_cont_cc 90383 day: 1 2 3 5 7 9 11 12 19

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), on successive days, saline control, DO [cm] dist_l60_cont_do 90384 day: 1 2 3 5 7 9 11 12 19

DO population w/par

9

both

8-21wks

N=26

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders [cm] dist_l60_cocaine_in 90385 day: 1 (saline) 2 (saline) 3 5 7 9 11 12 (saline) 19

inbred w/CC8

10

both

8-14wks

N=6

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, CC [cm] dist_l60_cocaine_cc 90386 day: 1 (saline) 2 (saline) 3 5 7 9 11 12 (saline) 19

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, DO [cm] dist_l60_cocaine_do 90387 day: 1 (saline) 2 (saline) 3 5 7 9 11 12 (saline) 19

DO population w/par

9

both

8-21wks

N=27

2018

CSNA03

operant conditioning chamber

(none)

protocol version (intravenous self administration), founders de_protocol_in 110186 categorical informational

inbred w/CC8

8

both

4-25wks

N=14

2018

CSNA03

operant conditioning chamber

(none)

exit reason (intravenous self administration), founders de_exit_reason_in 110187 categorical informational

inbred w/CC8

8

both

4-25wks

N=14

2018

CSNA03

operant conditioning chamber

(none)

exit reason (intravenous self administration), CC de_exit_reason_cc 110389 categorical informational

CC w/par

56

both

4-25wks

N=5

2018

CSNA03

operant conditioning chamber

(none)

exit reason (intravenous self administration), DO de_exit_reason_do 110259 categorical informational

DO population w/par

9

both

4-25wks

N=73

2018

CSNA03

operant conditioning chamber

cocaine

number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), founders [n] acquisition_in 110188

inbred w/CC8

7

both

4-25wks

N=10

2018

CSNA03

operant conditioning chamber

cocaine

number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), CC [n] acquisition_cc 110390

CC w/par

53

both

4-25wks

N=4

2018

CSNA03

operant conditioning chamber

cocaine

number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), DO [n] acquisition_do 110261

DO population w/par

8

both

4-25wks

N=48

2018

CSNA03

operant conditioning chamber

cocaine

dose response, number of infusions (intravenous self administration), founders [n] infusions_in 110189 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)

inbred w/CC8

8

both

4-25wks

N=14

2018

CSNA03

operant conditioning chamber

cocaine

dose response, number of infusions (intravenous self administration), CC [n] infusions_cc 110391 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)

CC w/par

57

both

4-25wks

N=6

2018

CSNA03

operant conditioning chamber

cocaine

dose response, number of infusions (intravenous self administration), DO [n] infusions_do 110262 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)

DO population w/par

9

both

4-25wks

N=73

2018

CSNA03

operant conditioning chamber

cocaine

extinction, active lever presses (intravenous self administration), founders [n] extinction_active_in 110198 session: 1 2 3 4 5 6 7 8 9

inbred w/CC8

7

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

cocaine

extinction, active lever presses (intravenous self administration), CC [n] extinction_active_cc 110400 session: 1 2 3 4 5 6 7 8 9

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

cocaine

extinction, active lever presses (intravenous self administration), DO [n] extinction_active_do 110271 session: 1 2 3 4 5 6 7 8 9

DO population w/par

8

both

4-25wks

N=39

2018

CSNA03

operant conditioning chamber

cocaine

extinction, inactive lever presses (intravenous self administration), founders [n] extinction_inactive_in 110207 session: 1 2 3 4 5 6 7 8 9

inbred w/CC8

7

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

cocaine

extinction, inactive lever presses (intravenous self administration), CC [n] extinction_inactive_cc 110409 session: 1 2 3 4 5 6 7 8 9

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

cocaine

extinction, inactive lever presses (intravenous self administration), DO [n] extinction_inactive_do 110280 session: 1 2 3 4 5 6 7 8 9

DO population w/par

8

both

4-25wks

N=39

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, active lever presses (intravenous self administration), founders [n] reinstatement_active_in 110216 session: 1 2

inbred w/CC8

7

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, active lever presses (intravenous self administration), CC [n] reinstatement_active_cc 110418 session: 1 2

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, active lever presses (intravenous self administration), DO [n] reinstatement_active_do 110289 session: 1 2 3

DO population w/par

8

both

4-25wks

N=42

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, inactive lever presses (intravenous self administration), founders [n] reinstatement_inactive_in 110218 session: 1 2

inbred w/CC8

7

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, inactive lever presses (intravenous self administration), CC [n] reinstatement_inactive_cc 110420 session: 1 2

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, inactive lever presses (intravenous self administration), DO [n] reinstatement_inactive_do 110292 session: 1 2 3

DO population w/par

8

both

4-25wks

N=42

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, number of infusions (intravenous self administration), founders [n] reinstatement_inf_in 110220 session: 1 2

inbred w/CC8

7

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, number of infusions (intravenous self administration), CC [n] reinstatement_inf_cc 110422 session: 1 2

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, number of infusions (intravenous self administration), DO [n] reinstatement_inf_do 110295 session: 1 2 3

DO population w/par

8

both

4-25wks

N=42

2018

CSNA03

operant conditioning chamber

(none)

number of days to meet criteria, (reversal learning assay), founders [n] days_criteria_in_JAX 110457 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

number of days to meet criteria, (reversal learning assay), CC [n] days_criteria_cc_JAX 110487 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

number of days to meet criteria, (reversal learning assay), DO [n] days_criteria_do_JAX 110517 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of trials (reversal learning assay), founders [n] trials_in_JAX 110459 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total number of trials (reversal learning assay), CC [n] trials_cc_JAX 110489 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of trials (reversal learning assay), DO [n] trials_do_JAX 110519 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

reversal trials minus acquisition trials (reversal learning assay), founders [n] diff_trials_rev_acq_in_JAX 113850

inbred w/CC8

8

both

N=7

2021

CSNA03

operant conditioning chamber

(none)

reversal trials minus acquisition trials (reversal learning assay), CC [n] diff_trials_rev_acq_cc_JAX 113851

CC w/par

52

both

N=3

2021

CSNA03

operant conditioning chamber

(none)

reversal trials minus acquisition trials (reversal learning assay), DO [n] diff_trials_rev_acq_do_JAX 113853

DO population w/par

9

both

N=28

2021

CSNA03

operant conditioning chamber

(none)

total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), founders [n] correct_in_JAX 110461 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC [n] correct_cc_JAX 110491 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), DO [n] correct_do_JAX 110521 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), founders [n] omit_in_JAX 110463 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC [n] omit_cc_JAX 110493 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), DO [n] omit_do_JAX 110523 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses that are correct (reversal learning assay), founders [%] pct_correct_in_JAX 110465 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses that are correct (reversal learning assay), CC [%] pct_correct_cc_JAX 110495 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses that are correct (reversal learning assay), DO [%] pct_correct_do_JAX 110525 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses considered omissions (reversal learning assay), founders [%] pct_omit_in_JAX 110467 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses considered omissions (reversal learning assay), CC [%] pct_omit_cc_JAX 110497 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses considered omissions (reversal learning assay), DO [%] pct_omit_do_JAX 110527 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total time for all trials (reversal learning assay), founders [min] total_time_in_JAX 110469 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total time for all trials (reversal learning assay), CC [min] total_time_cc_JAX 110499 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total time for all trials (reversal learning assay), DO [min] total_time_do_JAX 110529 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

latency (reversal learning assay), founders latency_in_JAX 110471 informational acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

latency (reversal learning assay), CC latency_cc_JAX 110501 informational acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

latency (reversal learning assay), DO latency_do_JAX 110531 informational acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders [centiseconds/n] trial_init_latency_in_JAX 110473 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), CC [centiseconds/n] trial_init_latency_cc_JAX 110503 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), DO [centiseconds/n] trial_init_latency_do_JAX 110533 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

retrieval (reversal learning assay), founders retrieval_in_JAX 110475 informational acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

retrieval (reversal learning assay), CC retrieval_cc_JAX 110505 informational acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

retrieval (reversal learning assay), DO retrieval_do_JAX 110535 informational acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

latency to retrieve reward per total correct responses (reversal learning assay), founders [centiseconds/n] reward_time_in_JAX 110477 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

latency to retrieve reward per total correct responses (reversal learning assay), CC [centiseconds/n] reward_time_cc_JAX 110507 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

latency to retrieve reward per total correct responses (reversal learning assay), DO [centiseconds/n] reward_time_do_JAX 110537 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_resp_left_in_JAX 110479 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_resp_left_cc_JAX 110509 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_resp_left_do_JAX 110539 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_resp_right_in_JAX 110481 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_resp_right_cc_JAX 110511 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_resp_right_do_JAX 110541 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_correct_in_JAX 110483 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_correct_cc_JAX 110513 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_correct_do_JAX 110543 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_incorrect_in_JAX 110485 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_incorrect_cc_JAX 110515 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_incorrect_do_JAX 110545 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of trials (reversal learning assay), founders [n] trials_in_Binghamton 112873 acquisition reversal

inbred w/CC8

8

both

N=6

2021

CSNA03

operant conditioning chamber

(none)

total number of trials (reversal learning assay), CC [n] trials_cc_Binghamton 112891 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

reversal trials minus acquisition trials (reversal learning assay), founders [n] diff_trials_rev_acq_in_Binghamton 113852

inbred w/CC8

8

both

N=5

2021

CSNA03

operant conditioning chamber

(none)

reversal trials minus acquisition trials (reversal learning assay), CC [n] diff_trials_rev_acq_cc_Binghamton 113854

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), founders [n] correct_in_Binghamton 112875 acquisition reversal

inbred w/CC8

8

both

N=6

2021

CSNA03

operant conditioning chamber

(none)

total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC [n] correct_cc_Binghamton 112893 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), founders [n] omit_in_Binghamton 112877 acquisition reversal

inbred w/CC8

8

both

N=5

2021

CSNA03

operant conditioning chamber

(none)

total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC [n] omit_cc_Binghamton 112895 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

percentage of responses that are correct (reversal learning assay), founders [%] pct_correct_in_Binghamton 112879 acquisition reversal

inbred w/CC8

8

both

N=6

2021

CSNA03

operant conditioning chamber

(none)

percentage of responses that are correct (reversal learning assay), CC [%] pct_correct_cc_Binghamton 112897 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

percentage of responses considered omissions (reversal learning assay), founders [%] pct_omit_in_Binghamton 112881 acquisition reversal

inbred w/CC8

8

both

N=5

2021

CSNA03

operant conditioning chamber

(none)

percentage of responses considered omissions (reversal learning assay), CC [%] pct_omit_cc_Binghamton 112899 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

total time for all trials (reversal learning assay), founders [min] total_time_in_Binghamton 112883 acquisition reversal

inbred w/CC8

8

both

N=6

2021

CSNA03

operant conditioning chamber

(none)

total time for all trials (reversal learning assay), CC [min] total_time_cc_Binghamton 112901 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders [centiseconds/n] trial_init_latency_in_Binghamton 112885 acquisition reversal

inbred w/CC8

8

both

N=6

2021

CSNA03

operant conditioning chamber

(none)

mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), CC [centiseconds/n] trial_init_latency_cc_Binghamton 112903 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_correct_in_Binghamton 112887 acquisition reversal

inbred w/CC8

8

both

N=5

2021

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_correct_cc_Binghamton 112905 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_incorrect_in_Binghamton 112889 acquisition reversal

inbred w/CC8

8

both

N=5

2021

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_incorrect_cc_Binghamton 112907 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

in vitro assay

(none)

peak-to-peak interval, indicating amount of time it takes for one cycle of bioluminescence circadian rhythm, in fibroblast cultures, founders [h] period_in 112539

inbred w/CC8

8

both

8-12wks

N=9

2020

CSNA03

in vitro assay

(none)

peak-to-peak interval, indicating amount of time it takes for one cycle of bioluminescence circadian rhythm, in fibroblast cultures, CC [h] period_cc 112544

CC w/par

40

both

8-12wks

N=4

2020

CSNA03

in vitro assay

(none)

specific time point when bioluminescence reaches highest circadian rhythm amplitude (cycle number), in fibroblast cultures, founders [n] phase_in 112540

inbred w/CC8

8

both

8-12wks

N=9

2020

CSNA03

in vitro assay

(none)

specific time point when bioluminescence reaches highest circadian rhythm amplitude (cycle number), in fibroblast cultures, CC [n] phase_cc 112545

CC w/par

40

both

8-12wks

N=4

2020

CSNA03

in vitro assay

(none)

peak-to-trough, indicating level of synchronization in circadian rhythm (max counts/s), in fibroblast cultures, founders [n/s] amplitude_in 112541

inbred w/CC8

8

both

8-12wks

N=9

2020

CSNA03

in vitro assay

(none)

peak-to-trough, indicating level of synchronization in circadian rhythm (max counts/s), in fibroblast cultures, CC [n/s] amplitude_cc 112546

CC w/par

40

both

8-12wks

N=4

2020

CSNA03

in vitro assay

(none)

number of days required for circadian rhythm amplitude to decrease to 36% of initial value, in fibroblast cultures, founders [days] damping_in 112542

inbred w/CC8

8

both

8-12wks

N=9

2020

CSNA03

in vitro assay

(none)

number of days required for circadian rhythm amplitude to decrease to 36% of initial value, in fibroblast cultures, CC [days] damping_cc 112547

CC w/par

40

both

8-12wks

N=4

2020

CSNA03

in vitro assay

(none)

percentage of observed rhythms that fit expected sine wave, indicating stability and robustness of circadian rhythm, in fibroblast cultures, founders [%] goodness_of_fit_in 112543

inbred w/CC8

8

both

8-12wks

N=9

2020

CSNA03

in vitro assay

(none)

percentage of observed rhythms that fit expected sine wave, indicating stability and robustness of circadian rhythm, in fibroblast cultures, CC [%] goodness_of_fit_cc 112548

CC w/par

40

both

8-12wks

N=4

2020

DiPetrillo2

urinalysis

(none)

microalbumin (urine MA) [mg/dL] MA 46101

CC pre w/par

163

m

10wks

N=2

2012

DiPetrillo2

urinalysis

(none)

creatinine (urine CREA) [mg/dL] CREA 46102

CC pre w/par

163

m

10wks

N=2

2012

DiPetrillo2

urinalysis

(none)

albumin-creatinine ratio (urine ACR) [mg/g] ACR 46103

CC pre w/par

163

m

10wks

N=2

2012

Ferris1

body weight

influenza A (H1N1) virus

body weight pre-infection (day 0) [g] bw_D0 47601

CC pre w/par

163

f

8-16wks

N=1

2012

Ferris1

body weight

influenza A (H1N1) virus

percent change in body weight, day 4 post-infection [%] bw_change 47602

CC pre w/par

163

f

8-16wks

N=1

2012

Ferris1

health assessment

influenza A (H1N1) virus

clinical score, day 4 post-infection (score 0-4) [score] clinical_score 47603

CC pre w/par

161

f

8-16wks

N=1

2012

Ferris1

health assessment

influenza A (H1N1) virus

susceptibility to viral infection index (0=susceptible; 1= resistant) [score] susceptibility_index 47605

CC pre w/par

161

f

8-16wks

N=1

2012

Ferris1

in vitro assay

influenza A (H1N1) virus

viral replication log titer, day 4 post-infection (lung) [n] titer 47606

CC pre w/par

162

f

8-16wks

N=1

2012

Ferris1

histopathology

influenza A (H1N1) virus

virus-induced airway inflammation, day 4 post-infection (score 0-3) [score] airway_inflam 47607

CC pre w/par

161

f

8-16wks

N=1

2012

Ferris1

histopathology

influenza A (H1N1) virus

virus-induced airway neutrophils, day 4 post-infection (score 0-3) [score] airway_neut 47608

CC pre w/par

140

f

8-16wks

N=1

2012

Ferris1

histopathology

influenza A (H1N1) virus

virus-induced airway damage, day 4 post-infection (score 0-3) [score] airway_damage 47609

CC pre w/par

160

f

8-16wks

N=1

2012

Ferris1

histopathology

influenza A (H1N1) virus

virus-induced vascular inflammation (lung), day 4 post-infection (score 0-3) [score] vascular_inflam 47610

CC pre w/par

161

f

8-16wks

N=1

2012

Ferris1

histopathology

influenza A (H1N1) virus

virus-induced alveolar inflammation, day 4 post-infection (score 0-3) [score] alveolar_inflam 47611

CC pre w/par

161

f

8-16wks

N=1

2012

Ferris1

histopathology

influenza A (H1N1) virus

virus-induced alveolar damage, day 4 post-infection (score 0-3) [score] alveolar_damage 47612

CC pre w/par

161

f

8-16wks

N=1

2012

Ferris1

histopathology

influenza A (H1N1) virus

virus-induced pulmonary edema, day 4 post-infection (score 0-3) [score] pulmonary_edema 47613

CC pre w/par

138

f

8-16wks

N=1

2012

GMC01

body weight

(none)

body weight [g] bw 55001

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC01

open field test

(none)

distance traveled, successive 5 min intervals [cm] distance 55011 1st 5min 2nd 5min 3rd 5min 4th 5min

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC01

open field test

(none)

distance traveled total, 20 min test [cm] distance_total 55015

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC01

open field test

(none)

number of rears, successive 5 min intervals [n] rears 55021 1st 5min 2nd 5min 3rd 5min 4th 5min

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC01

open field test

(none)

number of rears total, 20 min test [n] rears_total 55025

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC01

open field test

(none)

resting time in whole arena, 20 min test [s] whole_rest 55031

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC01

open field test

(none)

average speed in whole arena, 20 min test [cm/s] whole_speed 55032

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC01

open field test

(none)

distance traveled in center of arena, 20 min test [cm] center_distance 55041

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC01

open field test

(none)

resting time in center of arena, 20 min test [s] center_rest 55042

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC01

open field test

(none)

permanence time in center of arena, 20 min test [s] center_permanence 55043

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC01

open field test

(none)

average speed in center of arena, 20 min test [cm/s] center_speed 55044

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC01

open field test

(none)

latency to enter in center of arena, 20 min test [s] center_latency 55045

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC01

open field test

(none)

number of entries in center of arena, 20 min test [n] center_entries 55046

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC01

open field test

(none)

center distance, successive 5 min intervals [%] center_distance_series 55051 1st 5min 2nd 5min 3rd 5min 4th 5min

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC01

open field test

(none)

percentage of total distance in center, 20 min test [%] center_distance_total 55055

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC01

open field test

(none)

center time, successive 5 min intervals [%] center_time 55061 1st 5min 2nd 5min 3rd 5min 4th 5min

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC01

open field test

(none)

percentage of total time spent in center, 20 min test [%] center_time_total 55065

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC01

open field test

(none)

distance traveled in periphery, 20 min test [cm] periphery_distance 55071

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC01

open field test

(none)

resting time in periphery, 20 min test [s] periphery_rest 55072

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC01

open field test

(none)

permanence time in periphery, 20 min test [s] periphery_permanence 55073

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC01

open field test

(none)

average speed in periphery, 20 min test [cm/s] periphery_speed 55074

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC02

body weight

(none)

body weight [g] bw 55101

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC02

grip strength

(none)

forelimb grip strength [g] front_paws 55111 trial1 trial2 trial3

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC02

grip strength

(none)

forelimb grip strength, mean [g] front_paws_mean 55114

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC02

grip strength

(none)

forelimb grip strength (mean) normalized to body weight [ratio] front_paws_adj 55115

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC02

grip strength

(none)

forelimb and hindlimb grip strength [g] all_paws 55121 trial1 trial2 trial3

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC02

grip strength

(none)

forelimb and hindlimb grip strength, mean [g] all_paws_mean 55124

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC02

grip strength

(none)

forelimb and hindlimb grip strength (mean) normalized to body weight [ratio] all_paws_adj 55125

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

body weight

(none)

body weight [g] bw 55201

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

observation (SHIRPA)

(none)

coat appearance (1=tidy, 2=irregular) [score] coat_app 55211

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

observation (SHIRPA)

(none)

whiskers (0=present, 1=absent) [score] whiskers 55212

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

observation (SHIRPA)

(none)

body position (0=inactive, 1=active, 2=excessively active) [score] body_pos 55213

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

observation (SHIRPA)

(none)

pelvic elevation (0=less than 5, 1=5 or more, 2=no data) [score] pelvic_elev 55214

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

observation (SHIRPA)

(none)

tail elevation (0=dragging, 1=horizontal, 2=elevated) [score] tail_elev 55215

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

observation (SHIRPA)

(none)

transfer arousal (0=prolonged freeze, 1=brief freeze, 2=immediate movement) [score] transfer_arousal 55216

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

observation (SHIRPA)

(none)

defecation (0=present, 1=absent) [score] defecation 55221

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

observation (SHIRPA)

(none)

urination (0=present, 1=absent) [score] urinate 55222

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

observation (SHIRPA)

(none)

tremor (0=absent, 1=present) [score] tremor 55223

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

observation (SHIRPA)

(none)

total number of squares entered with all four paws in 30 s [n] loco_activity 55224

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

observation (SHIRPA)

(none)

evidence of biting (0=not aggressive, 1=aggressive) [score] bite_evidence 55225

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

observation (SHIRPA)

(none)

vocalization (0=no, 1=yes) [score] vocalization 55226

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

observation (SHIRPA)

(none)

palebral closure (0=open, 1=closed) [score] palebral_closure 55231

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

observation (SHIRPA)

(none)

lacrimation (0=absent, 1=present) [score] lacrimation 55232

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

observation (SHIRPA)

(none)

startle response, click box (0=no reaction, 1=Preyer reflex, 2=jumping) [score] startle_response 55233

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

observation (SHIRPA)

(none)

limb grasping (0=absent, 1=present) [score] limb_grasping 55241

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

observation (SHIRPA)

(none)

trunk curl (0=absent, 1=present) [score] trunk_curl 55242

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

observation (SHIRPA)

(none)

positional passivity (0=struggle, 3=no) [score] pos_pass 55243

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

observation (SHIRPA)

(none)

gait (0=fluid, 1=abnormal) [score] gait 55244

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

observation (SHIRPA)

(none)

touch escape (0=no response, 1=response to touch, 2=flees prior to touch) [score] touch_escape 55251

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

observation (SHIRPA)

(none)

pinna reflex (0=present, 1=absent) [score] pinna_reflex 55252

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

observation (SHIRPA)

(none)

corneal reflex (0=present, 1=absent) [score] cornea_reflex 55253

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC03

observation (SHIRPA)

(none)

contact righting reflex (0=present, 1=absent) [score] righting_reflex 55254

inbred w/CC8

8

both

8-10wks

N=17

2018

GMC04

body weight

(none)

body weight [g] bw 55301

inbred w/CC8

8

both

9-10wks

N=17

2018

GMC05

body weight

(none)

body weight [g] bw 55401

inbred w/CC8

8

both

9-10wks

N=17

2018

GMC05

acoustic startle test

(none)

acoustic startle response (ASR) [amplitude] ASR 55411 background noise 70dB 80dB 85dB 90dB 100dB 110dB 120dB

inbred w/CC8

8

both

9-10wks

N=17

2018

GMC05

acoustic startle test

(none)

acoustic startle response (ASR), 110 db sound pressure level [amplitude] ASR_PP 55421 67dB 69dB 73dB 81dB

inbred w/CC8

8

both

9-10wks

N=17

2018

GMC05

acoustic startle test

(none)

percent prepulse inhibition (PPI), 110 db sound pressure level [%] PPI 55431 67dB 69dB 73dB 81dB

inbred w/CC8

8

both

9-10wks

N=17

2018

GMC05

acoustic startle test

(none)

percentage prepulse inhibition (PPI) evoked by 110 dB sound pressure level with global prepulse stimulus [%] PPI_global 55435

inbred w/CC8

8

both

9-10wks

N=17

2018

GMC05

acoustic startle test

(none)

acoustic startle response (ASR) [amplitude] ASR_ISI 55441 inter-stimulus interval: 5 25 100

inbred w/CC8

8

both

9-10wks

N=17

2018

GMC05

acoustic startle test

(none)

prepulse inhibition (PPI) [%] PPI_ISI 55451 inter-stimulus interval: 5 25 100

inbred w/CC8

8

both

9-10wks

N=17

2018

GMC06

body weight

(none)

body weight [g] bw 55501 before fast after 16h fast

inbred w/CC8

8

both

10-11wks

N=14

2018

GMC07

body weight

(none)

body weight [g] bw 55601

inbred w/CC8

8

both

11-12wks

N=17

2018

GMC07

nociception assay

(none)

latency of nociceptive response to hot plate [s] latency 55611 reaction1 reaction2

inbred w/CC8

8

both

11-12wks

N=17

2018

GMC07

nociception assay

(none)

type of response to hot plate, first reaction (0=no reaction, 1=shake, 2=lick, 3=jump, 4=other) [designation] response_1 55621

inbred w/CC8

8

both

11-12wks

N=17

2018

GMC07

nociception assay

(none)

type of response to hot plate, second reaction (0=no reaction, 1=shake, 2=lick, 3=jump, 4=other) [designation] response_2 55622

inbred w/CC8

8

both

11-12wks

N=17

2018

GMC08

condenser chamber

(none)

transepidermal water loss, normalized [g/m²/h] TEWL_adj 55701

inbred w/CC8

8

both

11-12wks

N=17

2018

GMC08

condenser chamber

(none)

coefficient of variation of transepidermal water loss single measurements [%] TEWL_CV 55702

inbred w/CC8

8

both

11-12wks

N=17

2018

GMC08

condenser chamber

(none)

skin surface water loss [g/m²] SSWL 55703

inbred w/CC8

8

both

11-12wks

N=17

2018

GMC09

body weight

(none)

body weight before testing [g] bw_before 55801

inbred w/CC8

8

both

12-13wks

N=17

2018

GMC09

body weight

(none)

body weight after testing [g] bw_after 55802

inbred w/CC8

8

both

12-13wks

N=17

2018

GMC09

intake monitoring

(none)

total food intake, 21 h test [g] food 55811

inbred w/CC8

8

both

12-13wks

N=17

2018

GMC09

intake monitoring

(none)

total water consumption, 21 h test [mL] water 55821

inbred w/CC8

8

both

12-13wks

N=17

2018

GMC09

monitoring system

(none)

mean oxygen consumption, 21 h test, 15 min bins [mL/h] VO2_mean 55831

inbred w/CC8

8

both

12-13wks

N=17

2018

GMC09

monitoring system

(none)

mean carbon dioxide production, 21 h test, 15 min bins [mL/h] VCO2_mean 55832

inbred w/CC8

8

both

12-13wks

N=17

2018

GMC09

monitoring system

(none)

mean respiratory exchange rate, 21 h test, 15 min bins [ratio] RER_mean 55833

inbred w/CC8

8

both

12-13wks

N=17

2018

GMC09

monitoring system

(none)

mean heat production, 21 h test, 15 min bins [kJ/h] heat_mean 55841

inbred w/CC8

8

both

12-13wks

N=17

2018

GMC09

monitoring system

(none)

mean total beam breaks on X-axis, 21 h test, 15 min bins [n] breaks_X_mean 55851

inbred w/CC8

8

both

12-13wks

N=17

2018

GMC09

monitoring system

(none)

mean ambulatory movement on X-axis, 21 h test, 15 min bins [n] breaks_XA_mean 55852

inbred w/CC8

8

both

12-13wks

N=17

2018

GMC09

monitoring system

(none)

mean fine movement on X-axis, 21 h test, 15 min bins [n] breaks_XF_mean 55853

inbred w/CC8

8

both

12-13wks

N=17

2018

GMC09

monitoring system

(none)

mean ambulatory movement on Y-axis, 21 h test, 15 min bins [n] breaks_YA_mean 55854

inbred w/CC8

8

both

12-13wks

N=17

2018

GMC09

monitoring system

(none)

mean fine movement on Y-axis, 21 h test, 15 min bins [n] breaks_YF_mean 55855

inbred w/CC8

8

both

12-13wks

N=17

2018

GMC09

monitoring system

(none)

mean rearing movement on Z-axis, 21 h test, 15 min bins [n] breaks_Z_mean 55856

inbred w/CC8

8

both

12-13wks

N=17

2018

GMC09

monitoring system

(none)

mean distance traveled, 21 h test, 15 min bins [cm] distance_mean 55857

inbred w/CC8

8

both

12-13wks

N=17

2018

GMC09

monitoring system

(none)

mean speed traveled, 21 h test, 15 min bins [cm/s] speed_mean 55858

inbred w/CC8

8

both

12-13wks

N=17

2018

GMC10

body weight

(none)

body weight [g] bw 55901 age: 12-13wks 18-19wks

inbred w/CC8

8

both

N=17

2018

GMC10

NMR

(none)

fat tissue mass, whole body with head (NMR) [g] fat 55911 age: 12-13wks 18-19wks

inbred w/CC8

8

both

N=16

2018

GMC10

NMR

(none)

lean tissue mass, whole body with head (NMR) [g] lean 55921 age: 12-13wks 18-19wks

inbred w/CC8

8

both

N=16

2018

GMC11

body weight

(none)

body weight [g] bw 56001 before fast after 16h fast

inbred w/CC8

8

both

13-14wks

N=15

2018

GMC12

body weight

(none)

body weight [g] bw 56101

inbred w/CC8

8

both

14-15wks

N=13

2018

GMC12

echocardiography

(none)

respiration rate [n/min] resp_rate 56111

inbred w/CC8

8

both

14-15wks

N=15

2018

GMC12

echocardiography

(none)

heart rate, beats per min [n/min] heart_rate 56112

inbred w/CC8

8

both

14-15wks

N=17

2018

GMC12

echocardiography

(none)

left ventricular mass corrected [mg] LV_mass 56121

inbred w/CC8

8

both

14-15wks

N=17

2018

GMC12

echocardiography

(none)

fractional shortening [%] fract_shortening 56122

inbred w/CC8

8

both

14-15wks

N=17

2018

GMC12

echocardiography

(none)

ejection fraction [%] EJ_fraction 56123

inbred w/CC8

8

both

14-15wks

N=17

2018

GMC12

echocardiography

(none)

stroke volume, volume of blood pumped from one ventricle of the heart with each beat [µL] stroke_vol 56124

inbred w/CC8

8

both

14-15wks

N=17

2018

GMC12

echocardiography

(none)

cardiac output, volume of blood pumped by the heart per min [mL/min] cardiac_output 56125

inbred w/CC8

8

both

14-15wks

N=13

2018

GMC12

echocardiography

(none)

interventricular septum [mm] IVS 56131 diastole systole

inbred w/CC8

8

both

14-15wks

N=17

2018

GMC12

echocardiography

(none)

left ventricular internal dimension [mm] LVID 56133 diastole systole

inbred w/CC8

8

both

14-15wks

N=17

2018

GMC12

echocardiography

(none)

left ventricular posterior wall width [mm] LVPW 56135 diastole systole

inbred w/CC8

8

both

14-15wks

N=17

2018

GMC14

body size and weight

(none)

body weight [g] bw 56301

inbred w/CC8

8

both

14-16wks

N=13

2018

GMC14

body size and weight

(none)

body length [mm] body_length 56302

inbred w/CC8

8

both

14-16wks

N=13

2018

GMC14

organ dimensions

(none)

eye axial length [mm] eye_length 56321 left eye right eye

inbred w/CC8

8

both

15-16wks

N=13

2018

GMC14

Scheimpflug imaging

(none)

minimal density value of lens, Scheimpflug imaging [%] lens_min_density 56331 left eye right eye

inbred w/CC8

8

both

15-16wks

N=13

2018

GMC14

Scheimpflug imaging

(none)

maximal density value of lens, Scheimpflug imaging [%] lens_max_density 56333 left eye right eye

inbred w/CC8

8

both

15-16wks

N=13

2018

GMC14

Scheimpflug imaging

(none)

mean density value of lens, Scheimpflug imaging [%] lens_mean_density 56335 left eye right eye

inbred w/CC8

8

both

15-16wks

N=13

2018

GMC14

computed tomography

(none)

number of main vessels in fundus [n] fundus_vessels 56341 left eye right eye

inbred w/CC8

8

both

15-17wks

N=12

2018

GMC14

computed tomography

(none)

retinal thickness, optical coherence tomography [µm] retinal_thickness 56351 left eye right eye

inbred w/CC8

8

both

15-17wks

N=13

2018

GMC14

virtual optomotor

(none)

threshold of spatial frequency (number of cycles that fall within one degree of visual angle), virtual drum [n/deg] spatial_freq 56361

inbred w/CC8

3

both

14-16wks

N=16

2018

GMC15

complete blood count

(none)

white blood cell count (WBC; per volume x 10³) [n/µL] WBC 56401

inbred w/CC8

8

both

20-21wks

N=11

2018

GMC15

complete blood count

(none)

red blood cell count (RBC; per volume x 10⁶) [n/µL] RBC 56404

inbred w/CC8

8

both

20-21wks

N=11

2018

GMC15

complete blood count

(none)

RBC corpuscular distribution width (RDW) [%] RDW 56406

inbred w/CC8

8

both

20-21wks

N=11

2018

GMC15

complete blood count

(none)

mean RBC corpuscular volume (MCV) [fL] MCV 56408

inbred w/CC8

8

both

20-21wks

N=11

2018

GMC15

complete blood count

(none)

calculated mean RBC corpuscular hemoglobin content (MCH) [pg] MCH 56412

inbred w/CC8

8

both

20-21wks

N=11

2018

GMC15

complete blood count

(none)

calculated mean RBC corpuscular hemoglobin concentration (MCHC) [g/dL] MCHC 56414

inbred w/CC8

8

both

20-21wks

N=11

2018

GMC15

complete blood count

(none)

hemoglobin (HGB) [g/dL] HGB 56416

inbred w/CC8

8

both

20-21wks

N=11

2018

GMC15

complete blood count

(none)

hematocrit (HCT) [%] HCT 56421

inbred w/CC8

8

both

20-21wks

N=11

2018

GMC15

complete blood count

(none)

platelet count (PLT; units per volume x 10³) [n/µL] PLT 56431

inbred w/CC8

8

both

20-21wks

N=11

2018

GMC15

complete blood count

(none)

mean platelet volume (MPV) [fL] MPV 56434

inbred w/CC8

8

both

20-21wks

N=11

2018

GMC15

complete blood count

(none)

platelet corpuscular distribution width (PDW) [fL] PDW 56436

inbred w/CC8

8

both

20-21wks

N=11

2018

GMC15

complete blood count

(none)

platelet large cell ratio (PLCR) [%] PLCR 56438

inbred w/CC8

8

both

20-21wks

N=11

2018

GMC15

complete blood count

(none)

plateletcrit (PCT) [%] PCT 56441

inbred w/CC8

8

both

20-21wks

N=11

2018

GMC16

body weight

(none)

body weight [g] bw 56501 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=7

2018

GMC16

metabolic panel

(none)

calcium (plasma Ca) [mmol/L] calcium 56510 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=7

2018

GMC16

metabolic panel

(none)

chloride (plasma Cl) [mmol/L] chloride 56512 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=7

2018

GMC16

metabolic panel

(none)

iron (plasma Fe) [µmol/L] iron 56514 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=7

2018

GMC16

metabolic panel

(none)

unsaturated iron binding capacity (plasma UIBC) [µmol/L] iron_binding_21 56516

inbred w/CC8

6

both

N=3

2018

GMC16

metabolic panel

(none)

lactate (plasma) [mmol/L] lactate 56518 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=7

2018

GMC16

metabolic panel

(none)

phosphorus (plasma phosphate) [mmol/L] phosphate 56520 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=7

2018

GMC16

metabolic panel

(none)

potassium (plasma K) [mmol/L] potassium 56522 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=6

2018

GMC16

metabolic panel

(none)

sodium (plasma Na) [mmol/L] sodium 56524 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=6

2018

GMC16

metabolic panel

(none)

alkaline phosphatase (plasma ALP) [IU/L] ALP 56526 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=7

2018

GMC16

metabolic panel

(none)

alanine transaminase (plasma ALT) [IU/L] ALT 56528 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=7

2018

GMC16

metabolic panel

(none)

aspartate transaminase (plasma AST) [IU/L] AST 56530 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=6

2018

GMC16

metabolic panel

(none)

lactic acid dehydrogenase (plasma LDH) [IU/L] LDH 56532 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=6

2018

GMC16

metabolic panel

(none)

alpha-amylase (plasma) [IU/L] amylase 56534 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=7

2018

GMC16

metabolic panel

(none)

glucose (plasma GLU) [mmol/L] GLU 56536 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=7

2018

GMC16

metabolic panel

(none)

albumin (plasma Alb) [g/L] albumin 56538 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=7

2018

GMC16

metabolic panel

(none)

creatinine (plasma) [µmol/L] creatinine 56540 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=7

2018

GMC16

metabolic panel

(none)

total protein (plasma TP) [g/L] total_protein 56542 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=7

2018

GMC16

metabolic panel

(none)

blood urea nitrogen (plasma BUN) [mmol/L] urea 56544 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=7

2018

GMC16

lipid profile

(none)

total cholesterol (plasma CHOL) [mmol/L] CHOL 56546 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=7

2018

GMC16

lipid profile

(none)

triglyceride (plasma TG) [mmol/L] TG 56548 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=7

2018

GMC18

body size and weight

(none)

body weight [g] bw 56701

inbred w/CC8

8

both

17-18wks

N=12

2018

GMC18

body size and weight

(none)

body length [cm] body_length 56702

inbred w/CC8

7

both

17-18wks

N=13

2018

GMC18

body size and weight

(none)

body size (1=small, 2=normal, 3=big) [designation] body_size 56711

inbred w/CC8

8

both

17-18wks

N=12

2018

GMC18

colony observation

(none)

body type (1=emaciated, 2=slender, 3=normal, 4=pudgy/thick, 5=obese) [designation] body_type 56712

inbred w/CC8

8

both

17-18wks

N=12

2018

GMC18

DXA

(none)

fat tissue mass, without head [g] FATmass_Xhead 56721

inbred w/CC8

7

both

17-18wks

N=12

2018

GMC18

DXA

(none)

lean tissue mass, without head [g] LEANmass_Xhead 56722

inbred w/CC8

7

both

17-18wks

N=13

2018

GMC18

DXA

(none)

total soft tissue mass, without head [g] SOFTmass_Xhead 56723

inbred w/CC8

7

both

17-18wks

N=13

2018

GMC18

DXA

(none)

bone mineral density (BMD), without head [g/cm²] BMD_Xhead 56724

inbred w/CC8

7

both

17-18wks

N=13

2018

GMC18

DXA

(none)

bone area, without head [cm²] bone_area_Xhead 56725

inbred w/CC8

7

both

17-18wks

N=13

2018

GMC18

DXA

(none)

bone mass, without head [g] bone_mass_Xhead 56726

inbred w/CC8

7

both

17-18wks

N=13

2018

GMC18

DXA

(none)

bone mineral density (BMD), whole body including head [g/cm²] BMD_wholebody 56731

inbred w/CC8

7

both

17-18wks

N=13

2018

GMC18

DXA

(none)

fat tissue mass, whole body including head [g] FATmass_wholebody 56732

inbred w/CC8

7

both

17-18wks

N=12

2018

GMC18

DXA

(none)

lean tissue mass, whole body including head [g] LEANmass_wholebody 56733

inbred w/CC8

7

both

17-18wks

N=13

2018

GMC18

DXA

(none)

total soft tissue mass, whole body including head [g] SOFTmass_wholebody 56734

inbred w/CC8

7

both

17-18wks

N=13

2018

GMC18

DXA

(none)

bone area, whole body including head [cm²] bone_area_wholebody 56735

inbred w/CC8

7

both

17-18wks

N=13

2018

GMC18

DXA

(none)

bone mass, whole body including head [g] bone_mass_wholebody 56736

inbred w/CC8

7

both

17-18wks

N=13

2018

GMC18

X-ray

(none)

number of lumbar vertebrae [n] lumbar_num 56741

inbred w/CC8

8

both

17-18wks

N=12

2018

GMC19

body weight

(none)

body weight [g] bw 56801

inbred w/CC8

8

f

21-22wks

N=4

2018

GMC19

ventilator

(none)

residual volume (RV) in the lungs after a maximal exhalation [mL] residual_vol 56811

inbred w/CC8

7

f

21-22wks

N=3

2018

GMC19

ventilator

(none)

expiratory reserve volume (ERV), FVC minus IC [mL] expiratory_vol 56812

inbred w/CC8

8

f

21-22wks

N=3

2018

GMC19

ventilator

(none)

forced expiratory volume expired in first 100 ms of fast expiration (FEV100) [mL] forced_expiratory_vol 56813

inbred w/CC8

8

f

21-22wks

N=3

2018

GMC19

ventilator

(none)

tidal volume (TV) of air into or out of lungs during quiet breathing [mL] tidal_vol 56814

inbred w/CC8

8

f

21-22wks

N=4

2018

GMC19

ventilator

(none)

total lung capacity (TLC), volume in the lungs at maximal inflation, sum of VC and RV [mL] lung_capacity 56821

inbred w/CC8

7

f

21-22wks

N=3

2018

GMC19

ventilator

(none)

vital capacity (VC), volume of air breathed out after deepest inhalation [mL] vital_capacity 56822

inbred w/CC8

8

f

21-22wks

N=3

2018

GMC19

ventilator

(none)

forced vital capacity (FVC), volume expired during fast expiration [mL] forced_capacity 56823

inbred w/CC8

8

f

21-22wks

N=3

2018

GMC19

ventilator

(none)

inspiratory capacity (IC), volume inspired during slow inspiration [mL] inspiratory_capacity 56824

inbred w/CC8

8

f

21-22wks

N=3

2018

GMC19

ventilator

(none)

functional residual capacity (FRC), volume in lungs at end-expiratory position [mL] residual_capacity 56825

inbred w/CC8

8

f

21-22wks

N=3

2018

GMC19

ventilator

(none)

lung compliance (chord compliance) (H₂O pressure) [mL/cm] chord_compliance 56831

inbred w/CC8

8

f

21-22wks

N=3

2018

GMC19

ventilator

(none)

dynamic compliance (C) of respiratory system with breathing rate of 130/min (H₂O pressure) [mL/cm] dynamic_compliance 56832

inbred w/CC8

8

f

21-22wks

N=4

2018

GMC19

ventilator

(none)

respiratory system resistance (H₂O pressure) [cm/mL/s] resistance 56841

inbred w/CC8

8

f

21-22wks

N=4

2018

GMC19

ventilator

(none)

peak expiratory flow (PEF) [mL/s] peak_flow 56842

inbred w/CC8

8

f

21-22wks

N=3

2018

GMC20

immunoglobulin quantification

(none)

immunoglobulin M (plasma IgM) [µg/mL] IgM 56902 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=6

2018

GMC20

immunoglobulin quantification

(none)

immunoglobulin A (plasma IgA) [µg/mL] IgA 56904 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=5

2018

GMC20

immunoglobulin quantification

(none)

immunoglobulin G1 (plasma IgG1) [µg/mL] IgG1 56906 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=4

2018

GMC20

immunoglobulin quantification

(none)

immunoglobulin G2a (plasma IgG2a) [µg/mL] IgG2a 56908 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=6

2018

GMC20

immunoglobulin quantification

(none)

immunoglobulin G2b (plasma IgG2b) [µg/mL] IgG2b 56910 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=4

2018

GMC20

immunoglobulin quantification

(none)

immunoglobulin G3 (plasma IgG3) [µg/mL] IgG3 56912 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=6

2018

GMC20

immunoglobulin quantification

(none)

immunoglobulin E (plasma IgE) [ng/mL] IgE 56914 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=6

2018

GMC20

autoantibody quantification

(none)

anti-DNA autoantibodies (plasma) aDNA 56916 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=7

2018

GMC20

autoantibody quantification

(none)

rheumatoid factor (plasma RF) RF 56918 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=7

2018

GMC21

body weight

(none)

body weight [g] bw 57001

inbred w/CC8

8

both

21wks

N=11

2018

GMC21

bone dimensions

(none)

tibia length [mm] tibia_length 57002

inbred w/CC8

8

both

21wks

N=11

2018

GMC21

organ weights

(none)

heart weight [mg] heart_wt 57003

inbred w/CC8

8

both

21wks

N=11

2018

GMC21

organ weights

(none)

liver weight [g] liver_wt 57004

inbred w/CC8

8

both

21wks

N=11

2018

GMC21

organ weights

(none)

spleen weight [g] spleen_wt 57005

inbred w/CC8

8

both

21wks

N=11

2018

GMC22

body weight

(none)

body weight [g] bw 61901 8-9wks 9-10wks 11-12wks 12-13wks 13-14wks 14-15wks 16-17wks 17-18wks 20-21wks

inbred w/CC8

8

both

N=14

2018

Kumar3

None

(none)

CoatColor CoatColor 112909 categorical informational

inbred w/CC8

58

both

N=13

2021

Kumar3

None

(none)

CoatColor_numeric CoatColor_numeric 112910 informational

inbred w/CC8

58

both

N=13

2021

Kumar3

None

(none)

Sex_numeric Sex_numeric 112911 informational

inbred w/CC8

62

both

N=20

2021

Kumar3

body weight

(none)

body weight [g] Weight 112912

inbred w/CC8

62

both

8-14wks

N=19

2021

Kumar3

None

(none)

Box Box 112913 categorical informational

inbred w/CC8

62

both

N=20

2021

Kumar3

None

(none)

Box_numeric Box_numeric 112914 informational

inbred w/CC8

62

both

N=20

2021

Kumar3

None

(none)

TestAge TestAge 112915 informational

inbred w/CC8

62

both

N=20

2021

Kumar3

None

(none)

TestDate TestDate 112916 categorical informational

inbred w/CC8

62

both

N=20

2021

Kumar3

None

(none)

TestTime TestTime 112917 categorical informational

inbred w/CC8

62

both

N=19

2021

Kumar3

open field test

(none)

distance traveled in first 5 min [cm] OFDistTraveled5m 112918

inbred w/CC8

62

both

8-14wks

N=20

2021

Kumar3

open field test

(none)

distance traveled in first 20 min [cm] OFDistTraveled20m 112919

inbred w/CC8

62

both

8-14wks

N=20

2021

Kumar3

open field test

(none)

distance traveled in first 55 min [cm] OFDistTraveled55m 112920

inbred w/CC8

62

both

8-14wks

N=20

2021

Kumar3

open field test

(none)

time spent in periphery first 5 min [s] OFPeripheryTime5m 112921

inbred w/CC8

62

both

8-14wks

N=20

2021

Kumar3

open field test

(none)

time spent in periphery first 20 min [s] OFPeripheryTime20m 112922

inbred w/CC8

62

both

8-14wks

N=20

2021

Kumar3

open field test

(none)

time spent in periphery first 55 min [s] OFPeripheryTime55m 112923

inbred w/CC8

62

both

8-14wks

N=20

2021

Kumar3

open field test

(none)

time spent in corners first 5 min [s] OFCornerTime5m 112924

inbred w/CC8

62

both

8-14wks

N=20

2021

Kumar3

open field test

(none)

time spent in corners first 20 min [s] OFCornerTime20m 112925

inbred w/CC8

62

both

8-14wks

N=20

2021

Kumar3

open field test

(none)

time spent in corners first 55 min [s] OFCornerTime55m 112926

inbred w/CC8

62

both

8-14wks

N=20

2021

Kumar3

open field test

(none)

time spent grooming first 5 min [s] GrTime5m 112927

inbred w/CC8

62

both

8-14wks

N=20

2021

Kumar3

open field test

(none)

time spent grooming first 20 min [s] GrTime20m 112928

inbred w/CC8

62

both

8-14wks

N=20

2021

Kumar3

open field test

(none)

time spent grooming first 55 min [s] GrTime55m 112929

inbred w/CC8

62

both

8-14wks

N=20

2021

Kumar3

open field test

(none)

time spent grooming in first 55 min divided by 55 [] GrTimeSlope55m 112930

inbred w/CC8

62

both

8-14wks

N=20

2021

Kumar3

open field test

(none)

number of grooming events in first 5 min [n] GrBoutNum5m 112931

inbred w/CC8

62

both

8-14wks

N=20

2021

Kumar3

open field test

(none)

number of grooming events in first 20 min [n] GrBoutNum20m 112932

inbred w/CC8

62

both

8-14wks

N=20

2021

Kumar3

open field test

(none)

number of grooming events in first 55 min [n] GrBoutNum55m 112933

inbred w/CC8

62

both

8-14wks

N=20

2021

Kumar3

open field test

(none)

number of grooming events first 55 min divided by 55 [n/min] GrBoutNumSlope55m 112934

inbred w/CC8

62

both

8-14wks

N=20

2021

Kumar3

open field test

(none)

duration of grooming events first 5 min (s per event) [s/n] GrBoutLength5m 112935

inbred w/CC8

62

both

8-14wks

N=15

2021

Kumar3

open field test

(none)

duration of grooming events first 20 min (s per event) [s/n] GrBoutLength20m 112936

inbred w/CC8

62

both

8-14wks

N=19

2021

Kumar3

open field test

(none)

duration of grooming events first 55 min (s per event) [s/n] GrBoutLength55m 112937

inbred w/CC8

62

both

8-14wks

N=20

2021

Kumar3

open field test

(none)

average duration of grooming events first 55 min divided by 55 GrBoutLengthSlope55m 113846

inbred w/CC8

62

both

8-14wks

N=20

2021

Kumar3

open field test

(none)

time when animal grooms most during 55 min test [min] GrPeakMidBin 113847

inbred w/CC8

62

both

8-14wks

N=20

2021

Kumar3

open field test

(none)

amount of time spent grooming when animal grooms most (in 5 min range) [s] GrPeakVal 113848

inbred w/CC8

62

both

8-14wks

N=20

2021

Kumar3

open field test

(none)

amount of time spent grooming when animal grooms most divided by time when animal grooms most during first 55 min GrPeakSlope 113849

inbred w/CC8

62

both

8-14wks

N=20

2021

Kumar4

None

(none)

duration of test duration_of_test 114431 informational

inbred w/CC8

62

both

N=19

2021

Kumar4

body size and weight

(none)

distance from base of neck keypoint to center spine keypoint, plus center spine keypoint to base of tail keypoint, median [cm] body_length 114432

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

open field test

(none)

distance traveled during approximately one hour test [cm] distance 114433

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

number of strides, hind paws (keypoints) [n] stride_count 114434

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

angular velocity over duration of stride, mean [deg/s] angular_velocity_mean 114435

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

angular velocity over duration of stride, median [deg/s] angular_velocity_median 114436

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

angular velocity over duration of stride, variance [deg/s] angular_velocity_var 114437

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

lateral displacement of base of tail keypoint, mean base_tail_lateral_displacement_mean 114438

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

lateral displacement of base of tail keypoint, median base_tail_lateral_displacement_median 114439

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

lateral displacement of base of tail keypoint, variance base_tail_lateral_displacement_var 114440

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

limb duty factor, hind paws (keypoints), mean limb_duty_factor_mean 114441

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

limb duty factor, hind paws (keypoints), median limb_duty_factor_median 114442

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

limb duty factor, hind paws (keypoints), variance limb_duty_factor_var 114443

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

lateral displacement of nose keypoint, mean nose_lateral_displacement_mean 114444

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

lateral displacement of nose keypoint, median nose_lateral_displacement_median 114445

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

lateral displacement of nose keypoint, variance nose_lateral_displacement_var 114446

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

base tail keypoint speed, mean [cm/s] speed_mean 114447

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

base tail keypoint speed, median [cm/s] speed_median 114448

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

base tail keypoint speed, variance [cm/s] speed_var 114449

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

distance right hind paw keypoint travels past previous left hind paw keypoint strike, mean [cm] step_length1_mean 114450

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

distance right hind paw keypoint travels past previous left hind paw keypoint strike, median [cm] step_length1_median 114451

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

distance right hind paw keypoint travels past previous left hind paw keypoint strike, variance [cm] step_length1_var 114452

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

distance left hind paw keypoint travels past the right hind paw keypoint strike, mean [cm] step_length2_mean 114453

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

distance left hind paw keypoint travels past the right hind paw keypoint strike, median [cm] step_length2_median 114454

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

distance left hind paw keypoint travels past the right hind paw keypoint strike, variance [cm] step_length2_var 114455

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

lateral distance separating hind paws (keypoints), mean [cm] step_width_mean 114456

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

lateral distance separating hind paws (keypoints), median [cm] step_width_median 114457

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

lateral distance separating hind paws (keypoints), variance [cm] step_width_variance 114458

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

distance left hind paw keypoint travels for a stride, from toe-off to foot-strike, mean [cm] stride_length_mean 114459

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

distance left hind paw keypoint travels for a stride, from toe-off to foot-strike, median [cm] stride_length_median 114460

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

distance left hind paw keypoint travels for a stride, from toe-off to foot-strike, variance [cm] stride_length_var 114461

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

temporal symmetry of limb duty factor of hind paws (keypoints), mean temporal_symmetry_mean 114462

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

temporal symmetry of limb duty factor of hind paws (keypoints), median temporal_symmetry_median 114463

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

temporal symmetry of limb duty factor of hind paws (keypoints), variance temporal_symmetry_var 114464

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

lateral displacement of tip of tail keypoint, mean tip_tail_lateral_displacement_mean 114465

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

lateral displacement of tip of tail keypoint, median tip_tail_lateral_displacement_median 114466

inbred w/CC8

62

both

10-20wks

N=19

2021

Kumar4

gait analysis

(none)

lateral displacement of tip of tail keypoint, variance tip_tail_lateral_displacement_variance 114467

inbred w/CC8

62

both

10-20wks

N=19

2021

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are CD3- [%] CD3_neg 63501

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic CD3- lymphocytes that are NK cells (CD49+ CD19-) [%] NK_cells_of_CD3_neg 63502

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are NK cells (CD49+ CD19-) [%] NK_cells_of_tot 63503

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic NK cells that are CD27- CD11b- [%] CD27_neg_CD11b_neg 63504

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic NK cells that are CD27+ CD11b- [%] CD27_pos_CD11b_neg 63505

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic NK cells that are CD27+ CD11b+ [%] CD27_pos_CD11b_pos 63506

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic NK cells that are CD27- CD11b+ [%] CD27_neg_CD11b_pos 63507

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic NK cells that are pre-mNK (B220+ CD11c+) [%] pre_mNK_of_NK 63508

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are pre-mNK (B220+ CD11c+) [%] pre_mNK_of_tot 63509

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are NK T cells (TCRb+ CD1d+) [%] NKT_cells 63510

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic NK T cells that are CD4+ CD8- [%] CD4_pos_CD8_neg_of_NKT 63511

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are CD4+ NK T cells [%] CD4_pos_CD8_neg_NKT_of_tot 63512

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic NK T cells that are CD4- CD8- [%] CD4_neg_CD8_neg_of_NKT 63513

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are CD4- CD8- NK T cells [%] CD4_neg_CD8_neg_NKT_of_tot 63514

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are T cells [%] T_cells 63515

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic T cells that are CD4+ CD8- [%] CD4_pos_CD8_neg_of_Tcells 63516

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are CD4+ T cells [%] CD4_pos_CD8_neg_of_tot 63517

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic T cells that are CD4- CD8+ [%] CD4_neg_CD8_pos_of_Tcells 63518

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are CD8+ T cells [%] CD4_neg_CD8_pos_of_tot 63519

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic T cells that are CD4- CD8- [%] CD4_neg_CD8_neg_of_Tcells 63520

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are CD4- CD8- T cells [%] CD4_neg_CD8_neg_of_tot 63521

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

ratio of splenic CD4+ to CD8+ T cells [ratio] CD4_CD8_ratio 63522

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic leukocytes that are plasmacytoid dendritic cells [%] pDC 63523

CC w/par

74

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic leukocytes that are conventional dendritic cells [%] cDC 63524

CC w/par

74

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic conventional dendritic cells that are merocytic [%] mDC_of_cDC 63525

CC w/par

74

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic leukocytes that are merocytic dendritic cells [%] mDC_of_tot 63526

CC w/par

74

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic conventional dendritic cells that are cDC1 [%] cDC1_of_cDC 63527

CC w/par

74

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic leukocytes that are cDC1 conventional dendritic cells [%] cDC1_of_tot 63528

CC w/par

74

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic conventional dendritic cells that are cDC2 [%] cDC2_of_cDC 63529

CC w/par

74

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic leukocytes that are cDC2 conventional dendritic cells [%] cDC2_of_tot 63530

CC w/par

74

both

5-8wks

N=2

2018

Massett1

body weight

(none)

body weight [g] body_weight 46501

inbred w/CC8

34

m

8wks

N=6

2012

Massett1

treadmill endurance test

(none)

time spent exercising during graded exercise endurance test [min] exercise_dur 46502

inbred w/CC8

34

m

8wks

N=6

2012

Massett1

treadmill endurance test

(none)

distance traveled during graded exercise endurance test [m] exercise_dist 46503

inbred w/CC8

34

m

8wks

N=6

2012

Massett1

treadmill endurance test

(none)

vertical work performed during graded exercise endurance test [kg⋅m] exercise_work 46504

inbred w/CC8

34

m

8wks

N=6

2012

Mathes1

body weight

exercise

body weight [g] bw 45201 before exercise after exercise difference

CC pre w/par

184

m

10-12wks

N=1

2011

Mathes1

MRI

exercise

percent fat, whole body with head [%] pct_fat 45204 before exercise after exercise difference

CC pre w/par

184

m

10-12wks

N=1

2011

Mathes1

intake monitoring

exercise

caloric intake [kcal/d] calories 45207 before exercise during exercise

CC pre w/par

183

m

10-12wks

N=1

2011

Mathes1

monitoring system

(none)

nocturnal respiratory exchange ratio (RER) prior to wheel running (VCO2:VO2) [ratio] RER_pre 45209

CC pre w/par

138

m

10-12wks

N=1

2011

Mathes1

running wheel monitoring

(none)

distance traveled on wheel [m/d] run_dist 45210 day 1 day 6 day 12

CC pre w/par

184

m

10-12wks

N=1

2011

Mathes1

running wheel monitoring

(none)

speed on wheel [m/min] run_speed 45213 day 1 day 6 day 12

CC pre w/par

184

m

10-12wks

N=1

2011

Morgan1

body weight

(none)

starting body weight [g] bw_8 52601 control group treatment group

inbred w/CC8

9

f

8wks

N=4

2014

Morgan1

body weight

high-fat diet and olanzapine

percent change in body weight, age 10wks vs. 8wks [%] bwchg_10 52613 age 10wks: control treated

inbred w/CC8

9

f

10wks

N=4

2014

Morgan1

body weight

high-fat diet and olanzapine

percent change in body weight, age 12wks vs. 8wks [%] bwchg_12 52615 age 12wks: control treated

inbred w/CC8

9

f

12wks

N=4

2014

Morgan1

body weight

high-fat diet and olanzapine

percent change in body weight, age 14wks vs. 8wks [%] bwchg_14 52617 age 14wks: control treated

inbred w/CC8

9

f

14wks

N=4

2014

Morgan1

body weight

high-fat diet and olanzapine

percent change in body weight, age 16wks vs. 8wks [%] bwchg_16 52619 age 16wks: control treated

inbred w/CC8

9

f

16wks

N=4

2014

Odet1

body weight

(none)

body_weight [g] bw 53701

inbred w/CC8

8

m

10-66wks

N=29

2015

Odet1

organ weights

(none)

mean epididymis plus vas deferens weight [g] epidid_vasdef_wt 53711

inbred w/CC8

8

m

10-66wks

N=21

2015

Odet1

organ weights

(none)

seminal vesicles weight [g] seminal_ves_wt 53712

inbred w/CC8

8

m

10-66wks

N=27

2015

Odet1

organ weights

(none)

mean testis weight [g] testis_wt 53713

inbred w/CC8

8

m

10-66wks

N=27

2015

Odet1

histopathology

(none)

mean seminiferous tubule radius, transverse section [µm] seminif_radius 53721

inbred w/CC8

8

m

10-66wks

N=26

2015

Odet1

histopathology

(none)

seminiferious epithelium length, transverse section [cm] seminif_length 53722

inbred w/CC8

8

m

10-66wks

N=26

2015

Odet1

histopathology

(none)

number of seminiferous tubules, transverse section [n] seminif_count 53723

inbred w/CC8

8

m

10-66wks

N=26

2015

Odet1

histopathology

(none)

number of seminiferous tubules with vacuoles, transverse section [n] seminif_vacuoles 53724

inbred w/CC8

8

m

10-66wks

N=26

2015

Odet1

histopathology

(none)

number of seminiferous tubules with many vacuoles, transverse section [n] seminif_many_vacuoles 53725

inbred w/CC8

8

m

10-66wks

N=26

2015

Odet1

histopathology

(none)

number of seminiferous tubules with germ cell loss, transverse section [n] seminif_germ_loss 53726

inbred w/CC8

8

m

10-66wks

N=18

2015

Odet1

histopathology

(none)

number of seminiferous tubules with abnormal germ cells, transverse section [n] seminif_germ_abnormal 53727

inbred w/CC8

8

m

10-66wks

N=26

2015

Odet1

histopathology

(none)

number of seminiferous tubules with germ cell sloughing, transverse section [n] seminif_germ_slough 53728

inbred w/CC8

8

m

10-66wks

N=26

2015

Odet1

sperm count

(none)

sperm count per mouse (x 10⁶) [n] sperm_per_mouse 53731

inbred w/CC8

8

m

10-66wks

N=21

2015

Odet1

sperm count

(none)

sperm count per mg testis weight (x 10³) [n] sperm_per_testis 53732

inbred w/CC8

8

m

10-66wks

N=20

2015

Odet1

sperm count

(none)

sperm count per seminiferous epithelium length (x 10³) [n] sperm_per_seminif 53733

inbred w/CC8

8

m

10-66wks

N=19

2015

Odet1

histopathology

(none)

percentage of sperm with normal morphology [%] sperm_normal 53741

inbred w/CC8

8

m

10-66wks

N=14

2015

Odet1

histopathology

(none)

percentage of sperm with abnormal head shape [%] sperm_abnormal_head 53742

inbred w/CC8

8

m

10-66wks

N=14

2015

Odet1

histopathology

(none)

percentage of sperm with abnormal tail bending [%] sperm_abnormal_tail 53743

inbred w/CC8

8

m

10-66wks

N=14

2015

Odet1

histopathology

(none)

percentage of sperm with broken tails [%] sperm_broken_tail 53744

inbred w/CC8

8

m

10-66wks

N=14

2015

Odet1

metabolic panel

(none)

lactate production per 10⁸ sperm [µmole] sperm_lactate 53751

inbred w/CC8

8

m

10-66wks

N=8

2015

Odet2

microscopy

(none)

percentage of sperm that are motile [%] sperm_motile 53808 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

percentage of motile sperm that are 'progressive' [%] sperm_prog 53815 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

percentage of motile sperm that are 'intermediate' [%] sperm_int 53821 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

percentage of motile sperm that are 'hyperactivated' [%] sperm_hyper 53828 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

percentage of motile sperm that are 'vigorous' [%] sperm_vigor 53835 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

percentage of motile sperm that are 'slow' [%] sperm_slow 53841 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

percentage of motile sperm that are 'weak' [%] sperm_weak 53848 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

sperm mean path velocity [µm/s] sperm_VAP 53855 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

sperm mean straight line velocity [µm/s] sperm_VSL 53861 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

sperm mean curvilinear velocity [µm/s] sperm_VCL 53868 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

sperm mean lateral head displacement (amplitude) [µm] sperm_ALH 53875 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

sperm mean cross beat frequency [Hz] sperm_BCF 53881 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

sperm mean straightness [ratio] sperm_STR 53888 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

sperm mean linearity [ratio] sperm_LIN 53894 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Schughart3

body weight

(none)

body weight pre-infection [g] bw 57101 10 FFU group 2000 FFU group 200000 FFU group

inbred w/CC8

8

both

7-13wks

N=11

2013

Schughart3

body weight

influenza A (H3N2) virus

body weight as percent of baseline, 10 FFU group [%] pctbwA 57111 days post-infection: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

inbred w/CC8

8

both

7-13wks

N=9

2013

Schughart3

body weight

influenza A (H3N2) virus

body weight as percent of baseline, 2000 FFU group [%] pctbwB 57131 days post-infection: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

inbred w/CC8

8

both

7-13wks

N=9

2013

Schughart3

health assessment

influenza A (H3N2) virus

survival, post-infection [d] day_survival 57181 10 FFU group 2000 FFU group 200000 FFU group

inbred w/CC8

8

both

7-13wks

N=11

2013

Schughart3

health assessment

influenza A (H3N2) virus

susceptibility to viral infection (0=resistant, 1=susceptible), mortality rate [score] status_day_survival 57191 10 FFU group 2000 FFU group 200000 FFU group

inbred w/CC8

8

both

7-13wks

N=11

2013

Schughart4

body weight

(none)

body weight pre-infection [g] bw 58701 control group treated group

inbred w/CC8

8

f

8-12wks

N=13

2016

Schughart4

body weight

(none)

body weight as percent of baseline, control (saline) group [%] pctbw_ctrl 58711 days post-treatment (saline): 1 2 3

inbred w/CC8

8

f

8-12wks

N=6

2016

Schughart4

body weight

influenza A (H3N2) virus

body weight as percent of baseline, infected group [%] pctbw_trt 58721 days post-infection: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 18 30

inbred w/CC8

8

f

8-12wks

N=11

2016

Schughart4

complete blood count

influenza A (H3N2) virus

white blood cell count (WBC; per volume x 10³), control group, day 3 [n/µL] WBC_ctrl_d3 58741

inbred w/CC8

8

f

8-12wks

N=5

2016

Schughart4

complete blood count

influenza A (H3N2) virus

white blood cell count (WBC; per volume x 10³), treated group [n/µL] WBC_trt 58743 days post-infection: 3 5 8 18 30

inbred w/CC8

8

f

8-12wks

N=6

2016

Schughart4

complete blood count

influenza A (H3N2) virus

lymphocyte differential (percent of total WBC), control group, day 3 [%] pctLYM_ctrl_d3 58751

inbred w/CC8

8

f

8-12wks

N=5

2016

Schughart4

complete blood count

influenza A (H3N2) virus

lymphocyte differential (LYM; percentage of total WBC), treated group [%] pctLYM_trt 58753 days post-infection: 3 5 8 18 30

inbred w/CC8

8

f

8-12wks

N=6

2016

Schughart4

complete blood count

influenza A (H3N2) virus

monocyte differential (percent of total WBC), control group, day 3 [%] pctMONO_ctrl_d3 58761

inbred w/CC8

8

f

8-12wks

N=5

2016

Schughart4

complete blood count

influenza A (H3N2) virus

monocyte differential (MONO; percentage of total WBC), treated group [%] pctMONO_trt 58763 days post-infection: 3 5 8 18 30

inbred w/CC8

8

f

8-12wks

N=6

2016

Schughart4

complete blood count

influenza A (H3N2) virus

granulocyte differential (percent of total WBC), control group, day 3 [%] pctGRA_ctrl_d3 58771

inbred w/CC8

8

f

8-12wks

N=5

2016

Schughart4

complete blood count

influenza A (H3N2) virus

granulocyte differential (GRA; percentage of total WBC), treated group [%] pctGRA_trt 58773 days post-infection: 3 5 8 18 30

inbred w/CC8

8

f

8-12wks

N=6

2016

Schughart4

in vitro assay

influenza A (H3N2) virus

viral load in lungs (titer, FFU per lung) log10 (x+1) [log(n)] titer_trt 58783 days post-infection: 3 5 8

inbred w/CC8

8

f

8-12wks

N=5

2016

Schughart5

body weight

(none)

body weight pre-infection [g] bw 58801 control group treated group

inbred w/CC8

8

f

8-12wks

N=8

2016

Schughart5

body weight

(none)

body weight as percent of baseline [%] pctbw 58811 days post-treatment (saline): 1 2 3

inbred w/CC8

8

f

8-12wks

N=4

2016

Schughart5

body weight

influenza A (H3N2) virus

body weight as percent of baseline, 10 FFU group [%] pctbw_trt 58821 days post-infection: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 18 30

inbred w/CC8

8

f

8-12wks

N=9

2016

Schughart5

organ weights

influenza A (H3N2) virus

lung weight, control group, day 3 [g] lungwt_ctrl_d3 58881

inbred w/CC8

8

f

10wks

N=3

2016

Schughart5

organ weights

influenza A (H3N2) virus

lung weight, treated group [g] lungwt_trt 58883 days post-infection: 3 5 8 18 30

inbred w/CC8

8

f

10wks

N=4

2016

Schughart5

organ weights

influenza A (H3N2) virus

relative lung weight, control group, day 3 [%] lungwtadj_ctrl_d3 58891

inbred w/CC8

8

f

10wks

N=3

2016

Schughart5

organ weights

influenza A (H3N2) virus

relative lung weight, treated group [%] lungwtadj_trt 58893 days post-infection: 3 5 8 18 30

inbred w/CC8

8

f

10wks

N=4

2016

Shorter3

colony observation

(none)

number of weaned females [n] weaned_f 62301

CC diallel w/par

62

f

3wks

N=72

2018

Shorter3

colony observation

(none)

number of weaned males [n] weaned_m 62302

CC diallel w/par

62

f

3wks

N=72

2018

Shorter3

colony observation

(none)

total number weaned [n] weaned_tot 62303

CC diallel w/par

62

f

3wks

N=72

2018

Shorter3

colony observation

(none)

proportion of total weaned that are male [ratio] proportion_m 62304

CC diallel w/par

62

f

3wks

N=72

2018

Sunde1

body weight

(none)

body weight [g] bw 65301 day 20 day 28 day 35 day 42 day 49 day 56 day 63 day 70 day 77 day 84

inbred w/CC8

8

m

3-12wks

N=3

2018

Sunde1

RNA expression profiling

selenium

liver Dio1, mRNA abundance relative to C57BL/6J +Se [%] Dio1_mRNA 65311 Se deficient Se sufficient

inbred w/CC8

8

m

11-14wks

N=1

2018

Sunde1

RNA expression profiling

selenium

liver Gpx1, mRNA abundance relative to C57BL/6J +Se [%] Gpx1_mRNA 65313 Se deficient Se sufficient

inbred w/CC8

8

m

11-14wks

N=1

2018

Sunde1

RNA expression profiling

selenium

liver Gpx3, mRNA abundance relative to C57BL/6J +Se [%] Gpx3_mRNA 65315 Se deficient Se sufficient

inbred w/CC8

8

m

11-14wks

N=1

2018

Sunde1

RNA expression profiling

selenium

liver Gpx4, mRNA abundance relative to C57BL/6J +Se [%] Gpx4_mRNA 65317 Se deficient Se sufficient

inbred w/CC8

8

m

11-14wks

N=1

2018

Sunde1

RNA expression profiling

selenium

liver Msrb1, mRNA abundance relative to C57BL/6J +Se [%] Msrb1_mRNA 65319 Se deficient Se sufficient

inbred w/CC8

8

m

11-14wks

N=1

2018

Sunde1

RNA expression profiling

selenium

liver Selenof, mRNA abundance relative to C57BL/6J +Se [%] Selenof_mRNA 65321 Se deficient Se sufficient

inbred w/CC8

8

m

11-14wks

N=1

2018

Sunde1

RNA expression profiling

selenium

liver Selenoh, mRNA abundance relative to C57BL/6J +Se [%] Selenoh_mRNA 65323 Se deficient Se sufficient

inbred w/CC8

8

m

11-14wks

N=1

2018

Sunde1

RNA expression profiling

selenium

liver Selenok, mRNA abundance relative to C57BL/6J +Se [%] Selenok_mRNA 65325 Se deficient Se sufficient

inbred w/CC8

8

m

11-14wks

N=1

2018

Sunde1

RNA expression profiling

selenium

liver Selenom, mRNA abundance relative to C57BL/6J +Se [%] Selenom_mRNA 65327 Se deficient Se sufficient

inbred w/CC8

8

m

11-14wks

N=1

2018

Sunde1

RNA expression profiling

selenium

liver Selenon, mRNA abundance relative to C57BL/6J +Se [%] Selenon_mRNA 65329 Se deficient Se sufficient

inbred w/CC8

8

m

11-14wks

N=1

2018

Sunde1

RNA expression profiling

selenium

liver Selenoo, mRNA abundance relative to C57BL/6J +Se [%] Selenoo_mRNA 65331 Se deficient Se sufficient

inbred w/CC8

8

m

11-14wks

N=1

2018

Sunde1

RNA expression profiling

selenium

liver Selenop, mRNA abundance relative to C57BL/6J +Se [%] Selenop_mRNA 65333 Se deficient Se sufficient

inbred w/CC8

8

m

11-14wks

N=1

2018

Sunde1

RNA expression profiling

selenium

liver Selenos, mRNA abundance relative to C57BL/6J +Se [%] Selenos_mRNA 65335 Se deficient Se sufficient

inbred w/CC8

8

m

11-14wks

N=1

2018

Sunde1

RNA expression profiling

selenium

liver Selenot, mRNA abundance relative to C57BL/6J +Se [%] Selenot_mRNA 65337 Se deficient Se sufficient

inbred w/CC8

8

m

11-14wks

N=1

2018

Sunde1

RNA expression profiling

selenium

liver Selenow, mRNA abundance relative to C57BL/6J +Se [%] Selenow_mRNA 65339 Se deficient Se sufficient

inbred w/CC8

8

m

11-14wks

N=1

2018

Sunde1

RNA expression profiling

selenium

liver Txnrd1, mRNA abundance relative to C57BL/6J +Se [%] Txnrd1_mRNA 65341 Se deficient Se sufficient

inbred w/CC8

8

m

11-14wks

N=1

2018

Sunde1

RNA expression profiling

selenium

liver Txnrd2, mRNA abundance relative to C57BL/6J +Se [%] Txnrd2_mRNA 65343 Se deficient Se sufficient

inbred w/CC8

8

m

11-14wks

N=1

2018

Sunde1

RNA expression profiling

selenium

liver Txnrd3, mRNA abundance relative to C57BL/6J +Se [%] Txnrd3_mRNA 65345 Se deficient Se sufficient

inbred w/CC8

8

m

11-14wks

N=1

2018

Sunde1

protein activity assessment

selenium

liver Gpx1 enzyme activity (EU/g protein) [EU/g] Gpx1_act_liv 65347 Se deficient Se sufficient

inbred w/CC8

8

m

11-14wks

N=1

2018

Sunde1

protein activity assessment

selenium

RBC Gpx1 enzyme activity (EU/g protein) [EU/g] Gpx1_act_rbc 65349 Se deficient Se sufficient

inbred w/CC8

8

m

11-14wks

N=1

2018

Sunde1

protein activity assessment

selenium

plasma Gpx3 enzyme activity (EU/g protein) [EU/g] Gpx3_act 65351 Se deficient Se sufficient

inbred w/CC8

8

m

11-14wks

N=1

2018

Sunde1

protein activity assessment

selenium

liver Gpx4 enzyme activity (EU/g protein) [EU/g] Gpx4_act 65353 Se deficient Se sufficient

inbred w/CC8

8

m

11-14wks

N=1

2018

Sunde1

protein activity assessment

selenium

liver Txnrd enzyme activity (EU/g protein) [EU/g] Txnrd_act 65355 Se deficient Se sufficient

inbred w/CC8

8

m

11-14wks

N=1

2018

Filter Table Results